<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-179" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Catheter Management of Mitral Regurgitation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bora</surname>
            <given-names>Vaibhav</given-names>
          </name>
          <aff>Augusta University- Medical College of Georgia</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Brown</surname>
            <given-names>Kristen N.</given-names>
          </name>
          <aff>Augusta University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lim</surname>
            <given-names>Michael J.</given-names>
          </name>
          <aff>Saint Louis University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vaibhav Bora declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kristen Brown declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Lim declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-179.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Mitral regurgitation (MR) is a prevalent valvular abnormality, often requiring medical management or invasive surgery for severe cases. However, recent studies highlight the increased utilization of a minimally invasive transcatheter approach, particularly the edge-to-edge leaflet repair device. This catheter-based therapy employs a clip to&#x000a0;combine the mitral valve leaflets, effectively reducing regurgitation. The activity explores primary and secondary MR, providing insights into noninvasive catheter management options, indications, contraindications, procedural techniques, and potential complications. Emphasizing the role of interprofessional teams in patient care, the activity offers a comprehensive understanding of catheter-based therapies for MR.</p>
        <p>Clinicians engaging in this activity gain in-depth knowledge of primary and secondary MR, its categorization, and appropriate treatment choices based on disease duration and severity. The activity explores the nuances of echocardiography, emphasizing the significance of transthoracic and transesophageal imaging modalities in evaluating mitral valve morphology and pathology. Specifically, focusing on the edge-to-edge leaflet repair device gives clinicians a nuanced understanding of minimally invasive, catheter-based approaches. Clinicians enhance their expertise in managing&#x000a0;MR by comprehensively exploring indications, procedural techniques, and complications associated with noninvasive catheter interventions. Emphasis is placed on interprofessional collaboration, as it provides a holistic understanding of catheter-based therapies for MR, including indications and contraindications.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate between primary and secondary mitral regurgitation, recognizing the underlying etiology and determining the optimal management strategy for each type, considering factors such as left ventricular function,&#x000a0;left ventricular size, and atrial fibrillation.</p></list-item><list-item><p>Identify appropriate candidates for catheter management of mitral regurgitation based on a thorough assessment of valve morphology, pathology, and mechanism using transthoracic echocardiography and, when necessary, transesophageal echocardiography or cardiac magnetic resonance imaging.</p></list-item><list-item><p>Communicate effectively with patients, explaining the risks and benefits of catheter management of mitral regurgitation, ensuring informed consent, and addressing any concerns or questions regarding the procedure.</p></list-item><list-item><p>Collaborate with an interprofessional team, including cardiologists, imaging specialists, anesthesiologists, and nurses, to optimize patient care throughout the entire process, from preoperative evaluation to postprocedural monitoring.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=179&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=179">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-179.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Mitral regurgitation (MR) is one&#x000a0;of the most common valvular abnormalities, second only to aortic valve stenosis.<xref ref-type="bibr" rid="article-179.r1">[1]</xref><xref ref-type="bibr" rid="article-179.r2">[2]</xref>&#x000a0;Treatment depends on the duration and severity of this condition. Acute severe MR, often caused by papillary muscle rupture or leaflet perforation from infective endocarditis, leads to significant hemodynamic instability, acute volume overload, and congestion&#x02014;necessitating immediate surgical intervention.<xref ref-type="bibr" rid="article-179.r3">[3]</xref>&#x000a0;</p>
        <p>Chronic MR can be categorized into 2 types: primary and secondary. Primary MR is caused by a primary abnormality of 1 or more components of the valve apparatus (leaflets, chordae tendineae, papillary muscles, annulus).<bold>&#x000a0;</bold>In contrast, secondary MR is caused by alterations in left ventricular or left atrial function and shape. If mild and asymptomatic, chronic MR can be medically managed and monitored over time. However, patients with symptomatic chronic MR should undergo evaluation for potential surgical intervention.<xref ref-type="bibr" rid="article-179.r3">[3]</xref><xref ref-type="bibr" rid="article-179.r4">[4]</xref>&#x000a0;In cases of patients who are asymptomatic with chronic MR, surgical consideration may be warranted if they exhibit signs of depressed left ventricular&#x000a0;function and dilatation, atrial fibrillation, or pulmonary hypertension.<xref ref-type="bibr" rid="article-179.r5">[5]</xref><xref ref-type="bibr" rid="article-179.r6">[6]</xref></p>
        <p>Transthoracic echocardiography (TTE) is the initial imaging modality for screening and evaluating mitral valve morphology and pathology and determining the mechanism of MR. TTE also helps quantify the severity of MR and assess left ventricular function and size, and left atrial size.<xref ref-type="bibr" rid="article-179.r3">[3]</xref>&#x000a0;Various parameters are used for qualitative and quantitative MR assessment, including a 2-dimensional analysis of mitral valve leaflet characteristics, motion, coaptation, MR jet to left atrial area ratio, vena contracta, effective regurgitant orifice area, regurgitant volume, regurgitant area, left ventricular ejection fraction, and left ventricular end-diastolic area.</p>
        <p>In cases where TTE images do not provide adequate information, transesophageal echocardiography (TEE) can offer a more detailed assessment.<xref ref-type="bibr" rid="article-179.r7">[7]</xref><xref ref-type="bibr" rid="article-179.r8">[8]</xref>&#x000a0;Three-dimensional TEE can provide an "enface" view of the MV, resembling a surgical inspection, which can greatly aid discussions and preprocedure planning (see&#x000a0;<bold>Image.&#x000a0;</bold>Mitral Valve, En Face View). In situations where TEE is contraindicated, cardiac magnetic resonance imaging is an alternative option, providing highly accurate data for MR assessment and evaluation of left ventricle dimensions.</p>
        <p>Results from recent studies have shown percutaneous mitral valve repair as a viable alternative for high-surgical-risk patients suffering from severe symptomatic MR. This procedure has demonstrated low morbidity and mortality rates among many patients.<xref ref-type="bibr" rid="article-179.r9">[9]</xref>&#x000a0;The Endovascular Valve Edge-to-Edge Repair Study Trial (EVEREST) 1 laid the groundwork, demonstrating the safety and feasibility of the edge-to-edge repair technique. The subsequent EVEREST 2 randomized control trial compared percutaneous edge-to-edge repair with surgical mitral valve repair/replacement; this suggested the surgical approach's superiority in reducing MR but also supported the long-term safety of the edge-to-edge repair device and its durability in reducing MR.<xref ref-type="bibr" rid="article-179.r10">[10]</xref><xref ref-type="bibr" rid="article-179.r11">[11]</xref>&#x000a0;</p>
        <p>The edge-to-edge leaflet repair device is a minimally invasive, catheter-based therapy based on the principle of the "Alfieri stitch," a surgical technique pioneered by Dr. Ottavio Alfieri, an Italian cardiothoracic surgeon. This technique involves bringing together the 2 flailing leaflets of the MV, resulting in reduced or eliminated regurgitation. Typically, this repair creates a double orifice based on the surgical edge-to-edge Alfieri repair.<xref ref-type="bibr" rid="article-179.r12">[12]</xref><xref ref-type="bibr" rid="article-179.r13">[13]</xref></p>
        <p>Many percutaneous options exist for patients with MR and multiple comorbidities, placing them at higher risk for surgical interventions.<xref ref-type="bibr" rid="article-179.r14">[14]</xref>&#x000a0;These percutaneous techniques can be classified based on the specific site of the mitral apparatus they target, such as the leaflets (edge-to-edge repair), annulus (indirect or direct annuloplasty), chordae (neo-chords, percutaneous chord implantation), or left ventricle (percutaneous left ventricle remodeling).<xref ref-type="bibr" rid="article-179.r14">[14]</xref><xref ref-type="bibr" rid="article-179.r15">[15]</xref><xref ref-type="bibr" rid="article-179.r16">[16]</xref></p>
        <p>This article discusses primary and secondary MR and noninvasive catheter management options, including their indications, contraindications, procedural techniques, and complications. The primary focus of the discussion will be on the United States Food and Drug Administration's approved edge-to-edge repair devices.</p>
      </sec>
      <sec id="article-179.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>Andreas Vesalius first suggested the name "mitral" for the left-sided atrioventricular valve, given its resemblance with a bishop's miter.<xref ref-type="bibr" rid="article-179.r17">[17]</xref><xref ref-type="bibr" rid="article-179.r18">[18]</xref>&#x000a0;The mitral valve apparatus is a complex anatomic structure that includes the anterior and posterior mitral leaflets, mitral annulus, subvalvular structures (chordae tendineae, papillary muscles) and left ventricle (see&#x000a0;<bold>Images.&#x000a0;</bold>Mitral Valve Anatomy and Mitral Valve, Transverse View). The mitral annulus is a saddle-shaped structure; the competence of the mitral valve depends on the correct interaction of different components of the mitral valve apparatus.<xref ref-type="bibr" rid="article-179.r2">[2]</xref><xref ref-type="bibr" rid="article-179.r18">[18]</xref><xref ref-type="bibr" rid="article-179.r19">[19]</xref>&#x000a0;The anterior and posterior leaflets of the mitral valve should "coapt" to prevent MR during systole. An alteration in the functioning of any mitral valve component can lead to the development of MR.<xref ref-type="bibr" rid="article-179.r20">[20]</xref>&#x000a0;The 2 types of MR are primary and secondary. Primary MR is a degenerative valve disease, while secondary MR is characteristically a functional myocardial disease, ie, ventricular remodeling (see&#x000a0;<bold>Table 1.</bold>&#x000a0;Etiology of Mitral Regurgitation).</p>
        <table-wrap id="article-179.table0" position="float" orientation="portrait">
          <caption>
            <title>Table 1.&#x000a0;Etiology of Mitral Regurgitation</title>
          </caption>
          <table style="border-color: black; width: 795px; height: 0px;" border="1" cellspacing="1" cellpadding="5">
            <tbody>
              <tr style="height: 26px;">
                <td style="width: 226px; height: 26px; text-align: center;" rowspan="1" colspan="1">
<p><bold>Primary MR&#x000a0;</bold></p>
</td>
                <td style="width: 210.047px; height: 26px; text-align: center;" rowspan="1" colspan="1">
<bold>Secondary MR&#x000a0;</bold>
</td>
              </tr>
              <tr style="height: 39px;">
                <td style="width: 226px; height: 39px;" rowspan="1" colspan="1">MV prolapse - myxomatous changes (prolapse, filial, ruptured, elongated chordae)</td>
                <td style="width: 210.047px; height: 39px;" rowspan="1" colspan="1">Ischemia (due to&#x000a0;coronary artery disease )</td>
              </tr>
              <tr style="height: 26px;">
                <td style="width: 226px; height: 26px;" rowspan="1" colspan="1">Degenerative MR (calcification, thickening)</td>
                <td style="width: 210.047px; height: 26px;" rowspan="1" colspan="1">Nonischemic cardiomyopathy&#x000a0;</td>
              </tr>
              <tr style="height: 133px;">
                <td style="width: 226px; height: 133px;" rowspan="1" colspan="1">
<p>Infectious (infective endocarditis, vegetation, perforation)</p>
<p>Inflammatory (rheumatic, collagen vascular disease)</p>
<p>Drug-induced</p>
<p>Radiation-induced</p>
</td>
                <td style="width: 210.047px; height: 133px;" rowspan="1" colspan="1">Annular dilation&#x000a0;</td>
              </tr>
              <tr style="height: 26px;">
                <td style="width: 226px; height: 26px;" rowspan="1" colspan="1">Congenital (parachute mitral valve, cleft)</td>
                <td style="width: 210.047px; height: 26px;" rowspan="1" colspan="1">&#x000a0;&#x000a0;</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Primary and secondary MR&#x000a0;are further classified into stages A through D (see&#x000a0;<bold>Table 2.&#x000a0;</bold>Stages of Primary Mitral Regurgitation and <bold>Table 3.&#x000a0;</bold>Stages of Secondary&#x000a0;Mitral Regurgitation), indicating whether&#x000a0;they are mild, moderate, or severe.&#x000a0;Several interventions exist to treat severe MR, including surgical and nonsurgical. Patients with severe MR and who are at high or are a prohibitive risk for surgery are currently the only subset of patients recommended for catheter management. If untreated, severe MR can lead to fatal sequelae, including heart failure.<xref ref-type="bibr" rid="article-179.r21">[21]</xref>&#x000a0;</p>
        <table-wrap id="article-179.table1" position="float" orientation="portrait">
          <caption>
            <title>Table 2.&#x000a0;Stages of Primary Mitral Regurgitation</title>
          </caption>
          <table style="border-color: black; width: 795px;" border="1" cellspacing="1" cellpadding="5">
            <tbody>
              <tr style="height: 33px;">
                <td style="width: 10px; height: 33px; text-align: center;" rowspan="1" colspan="1">
<bold>Stage&#x000a0;</bold>
</td>
                <td style="width: 38px; height: 33px; text-align: center;" rowspan="1" colspan="1">
<bold>Definition&#x000a0;</bold>
</td>
                <td style="width: 160px; height: 33px; text-align: center;" rowspan="1" colspan="1">
<bold>Valve Anatomy</bold>
</td>
                <td style="width: 157px; height: 33px; text-align: center;" rowspan="1" colspan="1">
<bold>Valve Hemodynamics</bold>
</td>
                <td style="width: 119.344px; height: 33px; text-align: center;" rowspan="1" colspan="1">
<bold>Hemodynamic Consequences</bold>
</td>
                <td style="width: 55.6562px; height: 33px; text-align: center;" rowspan="1" colspan="1">
<bold>Symptoms</bold>
</td>
              </tr>
              <tr style="height: 29px;">
                <td style="width: 10px; height: 29px; text-align: center;" rowspan="1" colspan="1">A</td>
                <td style="width: 38px; height: 29px;" rowspan="1" colspan="1">At the risk of MR</td>
                <td style="width: 160px; height: 29px;" rowspan="1" colspan="1">
<p>Mild mitral valve prolapse with normal coaptation</p>
<p>Mild mitral valve thickening and leaflet restriction</p>
</td>
                <td style="width: 157px; height: 29px;" rowspan="1" colspan="1">
<p>No MR jet or small central jet area &#x0003c;20% left atrium on Doppler</p>
<p>Small vena contracta &#x0003c;0.3 cm</p>
</td>
                <td style="width: 119.344px; height: 29px;" rowspan="1" colspan="1">None&#x000a0;</td>
                <td style="width: 55.6562px; height: 29px;" rowspan="1" colspan="1">Absent</td>
              </tr>
              <tr style="height: 41px;">
                <td style="width: 10px; height: 41px; text-align: center;" rowspan="1" colspan="1">B</td>
                <td style="width: 38px; height: 41px;" rowspan="1" colspan="1">Progressive MR</td>
                <td style="width: 160px; height: 41px;" rowspan="1" colspan="1">
<p>Moderate to severe mitral valve prolapse with normal coaptation</p>
<p>Rheumatic valve changes with leaflet restriction and loss of central coaptation</p>
<p>Prior&#x000a0;infective endocarditis</p>
</td>
                <td style="width: 157px; height: 41px;" rowspan="1" colspan="1">
<p>Central jet MR 20% to 40% left atrium or late systolic eccentric jet MR &#x000a0;</p>
<p>Vena contracta &#x0003c;0.7 cm</p>
<p>Regurgitant volume &#x0003c;60 mL</p>
<p>Regurgitant fraction &#x0003c;50%</p>
<p>Effective regurgitant orifice&#x000a0;&#x0003c;0.40 cm<sup>2</sup> &#x000a0;</p>
<p>Angiographic grade 1+ to 2+</p>
</td>
                <td style="width: 119.344px; height: 41px;" rowspan="1" colspan="1">
<p>Mild left atrium enlargement</p>
<p>Left ventricle normal</p>
<p>Normal pulmonary pressure</p>
</td>
                <td style="width: 55.6562px; height: 41px;" rowspan="1" colspan="1">Absent</td>
              </tr>
              <tr style="height: 33px;">
                <td style="width: 10px; height: 33px; text-align: center;" rowspan="1" colspan="1">C</td>
                <td style="width: 38px; height: 33px;" rowspan="1" colspan="1">Asymptomatic severe MR</td>
                <td style="width: 160px; height: 33px;" rowspan="1" colspan="1">
<p>Severe&#x000a0;MV prolapse with loss of coaptation or flail leaflet &#x000a0;</p>
<p>Rheumatic valve changes with leaflet restriction and loss of central coaptation&#x000a0;</p>
<p>Prior&#x000a0;infective endocarditis</p>
<p>Thickening of leaflets with radiation heart disease</p>
</td>
                <td style="width: 157px; height: 33px;" rowspan="1" colspan="1">
<p>Central MR &#x0003e;40% left atrium area, holosystolic eccentric jet MR</p>
<p>Vena contracta &#x02265;0.7 cm</p>
<p>Regurgitant volume &#x02265;60 mL</p>
<p>Regurgitant fraction &#x02265;50%</p>
<p>Effective regurgitant orifice&#x000a0;&#x02265;0.4 cm<sup>2</sup></p>
<p>Angiographic grade 3+ to 4+</p>
</td>
                <td style="width: 119.344px; height: 33px;" rowspan="1" colspan="1">
<p>Moderate or severe left atrium enlargement</p>
<p>Left ventricle enlargement</p>
<p>Pulmonary hypertension may be present at rest or with exercise</p>
<p>C1: Left ventricular ejection fraction &#x0003e;60% and left ventricular end-systolic dimension&#x000a0;&#x0003c;40 mm</p>
<p>C2: Left ventricular ejection fraction&#x000a0;&#x02264;60% and/or &#x000a0;</p>
<p>Left ventricular end-systolic dimension &#x02265;40 mm</p>
</td>
                <td style="width: 55.6562px; height: 33px;" rowspan="1" colspan="1">Absent</td>
              </tr>
              <tr style="height: 31px;">
                <td style="width: 10px; height: 31px; text-align: center;" rowspan="1" colspan="1">D</td>
                <td style="width: 38px; height: 31px;" rowspan="1" colspan="1">Symptomatic severe MR</td>
                <td style="width: 160px; height: 31px;" rowspan="1" colspan="1">
<p>Severe mitral valve prolapse with loss of coaptation or flail leaflet &#x000a0;</p>
<p>Rheumatic valve changes with leaflet restriction and loss of central coaptation &#x000a0;</p>
<p>Prior infective endocarditis&#x000a0;</p>
<p>Thickening of leaflets with radiation heart disease</p>
</td>
                <td style="width: 157px; height: 31px;" rowspan="1" colspan="1">
<p>Central MR &#x0003e;40% left atrial area, holosystolic eccentric jet</p>
<p>Vena contracta&#x000a0;&#x02265;0.7 cm</p>
<p>Regurgitant volume &#x02265;60 mL</p>
<p>Regurgitant fraction &#x02265;50%</p>
<p>Effective regurgitant orifice&#x000a0;&#x000a0;&#x02265;0.4 cm<sup>2</sup></p>
<p>Angiographic grade 3+ to 4+</p>
</td>
                <td style="width: 119.344px; height: 31px;" rowspan="1" colspan="1">
<p>Moderate or severe left atrial enlargement</p>
<p>Left ventricular enlargement</p>
<p>Pulmonary hypertension present</p>
</td>
                <td style="width: 55.6562px; height: 31px;" rowspan="1" colspan="1">Dyspnea and reduced exercise tolerance</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Several valve hemodynamic criteria are provided for assessing MR, but not all criteria for each category will be present in each patient. Categorization of MR severity as mild, moderate, or severe depends on data quality and integration of these parameters in conjunction with other clinical evidence.<xref ref-type="bibr" rid="article-179.r3">[3]</xref></p>
        <p>&#x000a0;<bold>Table 3.&#x000a0;</bold>Stages of Secondary&#x000a0;Mitral Regurgitation</p>
        <table-wrap id="article-179.table2" position="float" orientation="portrait">
          <table style="border-color: black; width: 795px;" border="1" cellspacing="1" cellpadding="5">
            <tbody>
              <tr>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">
<bold>Stage</bold>
</td>
                <td style="width: 85px; text-align: center;" rowspan="1" colspan="1">
<bold>Definition</bold>
</td>
                <td style="width: 154px; text-align: center;" rowspan="1" colspan="1">
<bold>Valve Anatomy</bold>
</td>
                <td style="width: 192.078px; text-align: center;" rowspan="1" colspan="1">
<bold>Valve Hemodynamics</bold>
</td>
                <td style="width: 134.922px; text-align: center;" rowspan="1" colspan="1">
<bold>Associated Cardiac Findings</bold>
</td>
                <td style="width: 156px; text-align: center;" rowspan="1" colspan="1">
<bold>Symptoms</bold>
</td>
              </tr>
              <tr>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">A</td>
                <td style="width: 85px;" rowspan="1" colspan="1">At risk of MR</td>
                <td style="width: 154px;" rowspan="1" colspan="1">
<p>Normal mitral valve leaflets, chords, and annulus in a patient with coronary disease or cardiomyopathy</p>
</td>
                <td style="width: 192.078px;" rowspan="1" colspan="1">
<p>No MR jet or small central jet area &#x0003c;20% left atrium on Doppler</p>
<p>Small vena contracta &#x0003c;0.30 cm</p>
</td>
                <td style="width: 134.922px;" rowspan="1" colspan="1">
<p>Normal or mildly dilated left ventricle size with fixed (infarction) or inducible (ischemia) regional wall motion abnormalities</p>
<p>Primary myocardial disease with left ventricle dilation and systolic dysfunction</p>
</td>
                <td style="width: 156px;" rowspan="1" colspan="1">
<p>Symptoms due to coronary ischemia or heart failure may be present that respond to revascularization and appropriate medical therapy.</p>
</td>
              </tr>
              <tr>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">B</td>
                <td style="width: 85px;" rowspan="1" colspan="1">Progressive MR</td>
                <td style="width: 154px;" rowspan="1" colspan="1">Regional wall motion abnormalities with mild tethering of mitral leafletAnnular dilation with mild loss of central coaptation of the mitral leaflets</td>
                <td style="width: 192.078px;" rowspan="1" colspan="1">
<p>Effective regurgitant orifice&#x000a0;&#x0003c;0.40 cm<sup>2</sup></p>
<p>Regurgitant volume &#x0003c;60 mL</p>
<p>Regurgitant fraction &#x0003c;50%</p>
</td>
                <td style="width: 134.922px;" rowspan="1" colspan="1">
<p>Regional wall motion abnormalities with reduced left ventricle systolic function</p>
<p>Left ventricle dilation and&#x000a0;systolic dysfunction due to primary myocardial disease</p>
</td>
                <td style="width: 156px;" rowspan="1" colspan="1">
<p>Symptoms due to coronary ischemia or heart failure may be present that respond to revascularization and appropriate medical therapy.</p>
</td>
              </tr>
              <tr>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">C</td>
                <td style="width: 85px;" rowspan="1" colspan="1">Asymptomatic severe MR</td>
                <td style="width: 154px;" rowspan="1" colspan="1">
<p>Regional wall motion abnormalities and/or left ventricle dilation with severe tethering of mitral leaflet</p>
<p>Annular dilation with severe loss of central coaptation of the mitral leaflets</p>
</td>
                <td style="width: 192.078px;" rowspan="1" colspan="1">
<p>Effective regurgitant orifice&#x000a0;&#x02265;0.40 cm<sup>2</sup></p>
<p>Regurgitant volume &#x02265;60 mL</p>
<p>Regurgitant fraction &#x02265;50%</p>
</td>
                <td style="width: 134.922px;" rowspan="1" colspan="1">
<p>Regional wall motion abnormalities with reduced left ventricle &#x000a0;systolic function</p>
<p>Left ventricle dilation and systolic dysfunction due to primary myocardial disease</p>
</td>
                <td style="width: 156px;" rowspan="1" colspan="1">
<p>Symptoms due to coronary ischemia or heart failure may be present that respond to revascularization and appropriate medical therapy.</p>
</td>
              </tr>
              <tr>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">D</td>
                <td style="width: 85px;" rowspan="1" colspan="1">Symptomatic severe MR</td>
                <td style="width: 154px;" rowspan="1" colspan="1">
<p>Regional wall motion abnormalities and/or left ventricular dilation with severe tethering of mitral leaflet</p>
<p>Annular dilation with severe loss of central coaptation of the mitral leaflets</p>
</td>
                <td style="width: 192.078px;" rowspan="1" colspan="1">
<p>Effective regurgitant orifice &#x02265;0.40 cm<sup>2</sup></p>
<p>Regurgitant volume &#x02265;60 mL</p>
<p>Regurgitant fraction &#x02265;50%</p>
</td>
                <td style="width: 134.922px;" rowspan="1" colspan="1">
<p>Regional wall motion abnormalities with reduced left ventricle systolic function</p>
<p>Left ventricle dilation and systolic dysfunction due to primary myocardial disease</p>
</td>
                <td style="width: 156px;" rowspan="1" colspan="1">
<p>Heart failure symptoms due to MR persist even after revascularization and optimization of medical therapy.</p>
<p>Decreased exercise tolerance</p>
<p>Exertional dyspnea</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Several valve hemodynamic criteria are provided for assessing MR severity, but not all criteria for each category will be present in each patient. Categorization of MR severity as mild, moderate, or severe depends on data quality and integration of these parameters in conjunction with other clinical evidence. The measurement of the proximal iso velocity surface area by 2D TTE in patients with secondary MR underestimates the true ERO because of the crescentic shape of the proximal convergence.<xref ref-type="bibr" rid="article-179.r3">[3]</xref> &#x000a0;</p>
        <p>Echocardiography is the primary tool used to assess the structure and function of the MV, systolic competence, and nonrestriction during diastole. Various types of mitral valve leaflet motion can indicate the underlying reason for the dysfunction (see <bold>Table 4. </bold>Mitral Valve Pathology Based on Echocardiography).<xref ref-type="bibr" rid="article-179.r22">[22]</xref> Severe MR is described as having a color flow jet that may be central and large (&#x0003e;6 cm or &#x0003e;30% of the left atrium area) or smaller, if eccentric, encircling the left atrium. Pulmonary vein flow may show systolic blunting or systolic flow reversal, vena contracta width &#x02265;0.5 cm measured in the parasternal long-axis view, a regurgitant volume of &#x02265;45 mL/beat, regurgitant fraction &#x02265;40%, and/or regurgitant orifice area &#x02265;0.30 cm<sup>2</sup> according to the American College of Cardiology and American Heart Association.<xref ref-type="bibr" rid="article-179.r23">[23]</xref></p>
        <table-wrap id="article-179.table3" position="float" orientation="portrait">
          <caption>
            <title>Table 4. Mitral Valve Pathology Based on Echocardiography</title>
          </caption>
          <table style="border-color: black; width: 795px;" border="1" cellspacing="1" cellpadding="5">
            <tbody>
              <tr>
                <td style="width: 38px; text-align: center;" rowspan="1" colspan="1">
<bold>Type&#x000a0;</bold>
</td>
                <td style="width: 166.797px; text-align: center;" rowspan="1" colspan="1">
<bold>Leaflet Motion&#x000a0;</bold>
</td>
                <td style="width: 235.203px; text-align: center;" rowspan="1" colspan="1">
<bold>Example&#x000a0;</bold>
</td>
              </tr>
              <tr>
                <td style="width: 38px; text-align: center;" rowspan="1" colspan="1">I</td>
                <td style="width: 166.797px;" rowspan="1" colspan="1">Normal leaflet motion</td>
                <td style="width: 235.203px;" rowspan="1" colspan="1">
<p>Annular dilation without leaflet tethering</p>
<p>Cleft or indentation</p>
<p>Perforation</p>
</td>
              </tr>
              <tr>
                <td style="width: 38px; text-align: center;" rowspan="1" colspan="1">II</td>
                <td style="width: 166.797px;" rowspan="1" colspan="1">Excessive leaflet motion</td>
                <td style="width: 235.203px;" rowspan="1" colspan="1">
<p>Billowing</p>
<p>Prolapse</p>
<p>Flail leaflet</p>
</td>
              </tr>
              <tr>
                <td style="width: 38px; text-align: center;" rowspan="1" colspan="1">III</td>
                <td style="width: 166.797px;" rowspan="1" colspan="1">Restricted leaflet motion</td>
                <td style="width: 235.203px;" rowspan="1" colspan="1">
<p>Systolic restriction</p>
<list list-type="bullet"><list-item><p>Symmetric systolic &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p></list-item><list-item><p>Dilated or ischemic cardiomyopathy with leaflet tethering</p></list-item><list-item><p>Asymmetric systolic &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p></list-item><list-item><p>Segmental ischemia&#x000a0;</p></list-item></list>
<p>Systolic and diastolic restriction</p>
<list list-type="bullet"><list-item><p>Rheumatic</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 38px; text-align: center;" rowspan="1" colspan="1">IV</td>
                <td style="width: 166.797px;" rowspan="1" colspan="1">Systolic anterior motion&#x000a0;</td>
                <td style="width: 235.203px;" rowspan="1" colspan="1">
<p>Hypertrophic cardiomyopathy&#x000a0;</p>
<p>Post&#x000a0;MV repair</p>
</td>
              </tr>
              <tr>
                <td style="width: 38px; text-align: center;" rowspan="1" colspan="1">V</td>
                <td style="width: 166.797px;" rowspan="1" colspan="1">Mixed conditions&#x000a0;</td>
                <td style="width: 235.203px;" rowspan="1" colspan="1">Prolapse of&#x000a0;1 leaflet with restriction of another leaflet</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>
<bold>Preprocedural Anatomical Considerations</bold>
</p>
        <p>Certain conditions must be met to successfully grasp the mitral valve leaflets during transcatheter mitral valve repair. The leaflets must be pliable and noncalcified at the grasping site, and there must be no significant clefts or perforations. The shorter MitraClip clips NT and NTW also require a minimal posterior leaflet length of 6 mm. In comparison, the longer MitraClip clips XT and XTW require a minimal posterior leaflet length of 9 mm.<xref ref-type="bibr" rid="article-179.r24">[24]</xref>&#x000a0;Furthermore, a transmitral gradient of less than 5 mm Hg and a mitral valve area of at least 4 cm<sup>2</sup> are desirable to minimize the risk of mitral stenosis. If the mitral valve area is &#x02264;3 cm<sup>2</sup>, it is considered a contraindication for mitral transcatheter edge-to-edge repair (TEER), and the decision to proceed in borderline cases can be individualized based on the severity and location of MR and the anticipated number of devices needed. The mitral valve area should be measured using 3-dimensional (3D) multiplanar reformatting to avoid overestimation errors.</p>
        <p>Patients with an extensive flail, defined as a flail segment width of 15 mm or greater or a flail gap of 10 mm or greater, were not included in the initial clinical trials for TEER therapy, such as EVEREST 2.<xref ref-type="bibr" rid="article-179.r10">[10]</xref>&#x000a0;Despite this, treating degenerative mitral valve disease with a flail leaflet is an important application of TEER therapy; this condition can be associated with higher mortality risk in older individuals.<xref ref-type="bibr" rid="article-179.r25">[25]</xref>&#x000a0;The presence of a flail leaflet segment can predict a greater acute improvement in mean left atrium pressure after TEER. Improvement in left atrium pressure after TEER has been linked to improved functional status.<xref ref-type="bibr" rid="article-179.r26">[26]</xref>&#x000a0;Treating wider and larger flail gaps is now possible with the availability of longer and wider TEER devices. The development of independent leaflet grasping technology has enabled the treatment of larger and wider flail gaps. This technology is available with the MitraClip G4 and the PASCAL transcatheter mitral valve repair systems, allowing for the initial capture of the flail segment, followed by the steering of the delivery system to the nonflail leaflet. (This ensures both leaflets have a sufficient and stable grasp, thus facilitating the treatment of larger and wider flail gaps.)</p>
        <p>In its selection criteria, the EVEREST 2 trial only enrolled patients with a primary regurgitant mitral jet originating from the central region of the mitral valve, specifically the A2-P2 segments.<xref ref-type="bibr" rid="article-179.r10">[10]</xref>&#x000a0;However, this approach led to a significant portion of patients with noncentral MR being excluded from TEER treatment, leaving them untreated. Noncentral MR, which originates from the commissures and extends to involve the leaflet edges, constitutes nearly a third of all cases of significant MR.<xref ref-type="bibr" rid="article-179.r27">[27]</xref><xref ref-type="bibr" rid="article-179.r28">[28]</xref>&#x000a0;When deploying TEER devices in these cases, unique challenges emerge, particularly when dealing with large prolapsing leaflets and flail segments closer to the medial and lateral commissures. The complexity and increased number of chordae tendineae in the commissures elevate the risk of device entanglement and chordal disruption. To mitigate this risk, some operators opt for smaller TEER devices to avoid entanglement, as longer device arms increase the likelihood of such complications. Fortunately, the shorter posterior leaflet length in the commissures often makes short device arms sufficient for achieving adequate tissue grasp (ie, &#x0003c;9 mm). Extensive use of 3D transthoracic echocardiography and unconventional imaging planes proves valuable in visualizing the full extent of the pathology, informing device choice, and ensuring proper orientation.<xref ref-type="bibr" rid="article-179.r29">[29]</xref></p>
        <p>Patients with severe leaflet prolapse, known as Barlow disease, were not included in the EVEREST trials due to their challenges for a successful TEER. The hypermobility of the leaflets makes them difficult to grasp, necessitating multiple large TEER devices to achieve significant height reduction of the redundant leaflet tissue and a longer-lasting reduction in MR, making the procedure even more challenging.<xref ref-type="bibr" rid="article-179.r30">[30]</xref></p>
        <p>When considering TEER in secondary MR, it is important to differentiate patients with preserved left ventricular function and annular dilation (atrial functional MR) from those with left ventricular dysfunction and leaflet tethering. A subgroup analysis of the 2018 Cardiovascular Outcomes Assessment of the Mitra Clip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation trial demonstrated that patients with atrial fibrillation who underwent TEER maintained a clinical benefit. However, they exhibited a worse prognosis compared to patients without atrial fibrillation.<xref ref-type="bibr" rid="article-179.r31">[31]</xref></p>
        <p>Mitral annular calcification is a degenerative process that primarily affects the mitral valve annulus and is often associated with MR.<xref ref-type="bibr" rid="article-179.r32">[32]</xref>&#x000a0;Grasping the thickened and stiffened leaflets in these cases can be challenging. Moreover, patients with reduced mitral valve area at baseline face an increased risk of high diastolic gradients across the mitral annulus. Recent study results suggest that, in select patients with mitral annulus calcification and severe MR, TEER therapy may be a safe and feasible option with comparable midterm outcomes.<xref ref-type="bibr" rid="article-179.r33">[33]</xref></p>
        <p>A noteworthy concern in mitral valve surgery is that up to 35% of patients who have previously undergone surgical mitral valve repair at high-volume centers of excellence develop moderate to severe MR a decade after their initial repair.<xref ref-type="bibr" rid="article-179.r34">[34]</xref><xref ref-type="bibr" rid="article-179.r35">[35]</xref><xref ref-type="bibr" rid="article-179.r36">[36]</xref>&#x000a0;Redo sternotomy in these patients is often associated with a high risk of morbidity and mortality.<xref ref-type="bibr" rid="article-179.r37">[37]</xref>&#x000a0;While results from some studies have demonstrated the safety and feasibility of TEER in these situations, further research is essential to assess its efficacy fully.<xref ref-type="bibr" rid="article-179.r38">[38]</xref><xref ref-type="bibr" rid="article-179.r39">[39]</xref><xref ref-type="bibr" rid="article-179.r40">[40]</xref>&#x000a0;</p>
        <p>Recognizing individuals who have previously undergone surgical annuloplasty often have a reduced mitral valve area due to the presence of the annuloplasty ring is crucial. Given that more than 1 TEER device is typically needed to reduce MR effectively, the procedural team must exercise caution to prevent a subsequent increase in diastolic inflow gradients. In postsurgical mitral valve repair cases, the posterior mitral valve leaflet is often resected, resulting in a shorter and smaller posterior leaflet that can prove more challenging to grasp during the TEER procedure. An alternative strategy involves grasping the anterior and posterior sections of the annuloplasty ring when the posterior leaflet tissue length is insufficient. However, expertise with this technique is somewhat limited. Furthermore, the visibility of the posterior leaflet is often restricted due to an annuloplasty ring, making leaflet grasping particularly challenging during TEER. In these scenarios, there is an elevated risk of device entanglement, especially in the presence of artificial chords.<xref ref-type="bibr" rid="article-179.r41">[41]</xref></p>
        <p>Preprocedural TEE examination also helps predict the repair difficulty (see&#x000a0;<bold>Table 5</bold>. Echocardiography Predictors of Transcatheter Edge-to-Edge Repair Difficulties).<xref ref-type="bibr" rid="article-179.r8">[8]</xref><xref ref-type="bibr" rid="article-179.r42">[42]</xref><xref ref-type="bibr" rid="article-179.r43">[43]</xref></p>
        <table-wrap id="article-179.table4" position="float" orientation="portrait">
          <caption>
            <title>Table 5. Echocardiography Predictors of Transcatheter Edge-to-Edge Repair Difficulties</title>
          </caption>
          <table style="border-color: black; width: 795px;" border="1" cellspacing="1" cellpadding="5">
            <tbody>
              <tr>
                <td style="text-align: center; width: 153px;" rowspan="1" colspan="1">
<bold>&#x000a0;Echocardiographic Criterion&#x000a0;</bold>
</td>
                <td style="text-align: center; width: 154.234px;" rowspan="1" colspan="1"><bold>Ideal Anatomic Features</bold>&#x000a0;</td>
                <td style="text-align: center; width: 223.766px;" rowspan="1" colspan="1">
<bold>Challenging Anatomic Features&#x000a0;</bold>
</td>
                <td style="text-align: center; width: 208px;" rowspan="1" colspan="1">
<bold>Relative Contraindications&#x000a0;</bold>
</td>
              </tr>
              <tr>
                <td style="width: 153px;" rowspan="1" colspan="1">Anatomic location of pathology&#x000a0;</td>
                <td style="width: 154.234px;" rowspan="1" colspan="1">Regurgitation jet in A2-P2 segment&#x000a0;</td>
                <td style="width: 223.766px;" rowspan="1" colspan="1">Involves medial or lateral commissure, segments A1-P1, A3-P3</td>
                <td style="width: 208px;" rowspan="1" colspan="1">Perforation, cleft, or severe calcification of leaflet</td>
              </tr>
              <tr>
                <td style="width: 153px;" rowspan="1" colspan="1">MV area and gradient&#x000a0;</td>
                <td style="width: 154.234px;" rowspan="1" colspan="1">
<p>Area &#x0003e;4 cm<sup>2 </sup></p>
<p>Gradient &#x0003c;4 mm Hg</p>
</td>
                <td style="width: 223.766px;" rowspan="1" colspan="1">
<p>&#x000a0;Area &#x0003e;3.5 cm<sup>2</sup></p>
<p>&#x000a0;Gradient &#x02265;4 mm Hg</p>
</td>
                <td style="width: 208px;" rowspan="1" colspan="1">
<p>&#x000a0;Area &#x0003c;3.5 cm<sup>2</sup></p>
<p>&#x000a0;gradient &#x02265;4 mm Hg</p>
</td>
              </tr>
              <tr>
                <td style="width: 153px;" rowspan="1" colspan="1">&#x000a0;Leaflet grasping length</td>
                <td style="width: 154.234px;" rowspan="1" colspan="1">&#x000a0;&#x0003e;10 mm</td>
                <td style="width: 223.766px;" rowspan="1" colspan="1">&#x000a0;7 to 10 mm&#x000a0;</td>
                <td style="width: 208px;" rowspan="1" colspan="1">&#x000a0;&#x0003c;7 mm</td>
              </tr>
              <tr>
                <td style="width: 153px;" rowspan="1" colspan="1">&#x000a0;Secondary MR&#x000a0;</td>
                <td style="width: 154.234px;" rowspan="1" colspan="1">Coaptation depth &#x0003c;11 mm</td>
                <td style="width: 223.766px;" rowspan="1" colspan="1">Coaptation depth &#x0003e;11 mm&#x000a0;</td>
                <td style="width: 208px;" rowspan="1" colspan="1">Rheumatic thickening and restriction&#x000a0;</td>
              </tr>
              <tr>
                <td style="width: 153px;" rowspan="1" colspan="1">&#x000a0;Primary MR</td>
                <td style="width: 154.234px;" rowspan="1" colspan="1">
<p>Flail width &#x0003c;15 mm</p>
<p>Flail gap &#x0003c;10 mm</p>
</td>
                <td style="width: 223.766px;" rowspan="1" colspan="1">Flail width &#x0003e;15 mm with a large valve area&#x000a0;</td>
                <td style="width: 208px;" rowspan="1" colspan="1">Barlow disease with multisegment involvement&#x000a0;</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-179.s4" sec-type="Indications">
        <title>Indications</title>
        <p>The edge-to-edge leaflet repair device is the only recommended intervention to treat MR. Still, there are many emerging technologies, including but not limited to neo-cords, transcatheter mitral valve repair, and rings. The following are currently the indications for the edge-to-edge repair:</p>
        <list list-type="bullet">
          <list-item>
            <p>Moderate to severe primary MR&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Moderate to severe secondary MR&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Symptomatic heart failure</p>
          </list-item>
          <list-item>
            <p>High or prohibitive risk for surgery&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Favorable anatomy</p>
          </list-item>
          <list-item>
            <p>Life expectancy &#x0003e;1 year&#x000a0;<xref ref-type="bibr" rid="article-179.r44">[44]</xref><xref ref-type="bibr" rid="article-179.r45">[45]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-179.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>A few contraindications to catheter intervention with the edge-to-edge leaflet repair device include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Inability&#x000a0;to tolerate anticoagulation</p>
          </list-item>
          <list-item>
            <p>Active endocarditis of the mitral valve</p>
          </list-item>
          <list-item>
            <p>Rheumatic mitral valve disease&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Intracardiac, inferior vena cava, or femoral venous thrombus</p>
          </list-item>
          <list-item>
            <p>Severe mitral annular calcification involving leaflets</p>
          </list-item>
          <list-item>
            <p>Presence of significant cleft or perforation in mitral valve&#x000a0;leaflets</p>
          </list-item>
          <list-item>
            <p>Mitral valve stenosis&#x000a0;<xref ref-type="bibr" rid="article-179.r46">[46]</xref><xref ref-type="bibr" rid="article-179.r47">[47]</xref><xref ref-type="bibr" rid="article-179.r48">[48]</xref>&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-179.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>The following supplies are needed to perform a transcatheter edge-to-edge leaflet repair procedure:</p>
        <list list-type="bullet">
          <list-item>
            <p>The edge-to-edge leaflet repair device</p>
          </list-item>
          <list-item>
            <p>Transeptal puncture kit including catheters, needles, and a radiofrequency wire</p>
          </list-item>
          <list-item>
            <p>Fluoroscopy machine</p>
          </list-item>
          <list-item>
            <p>Code cart with a defibrillator</p>
          </list-item>
          <list-item>
            <p>Sterile gown</p>
          </list-item>
          <list-item>
            <p>Sterile drape</p>
          </list-item>
          <list-item>
            <p>Anesthetic</p>
          </list-item>
          <list-item>
            <p>Transesophageal echocardiography, preferably with 3D imaging capability</p>
          </list-item>
          <list-item>
            <p>Transducers and equipment for invasive hemodynamic monitoring&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Availability of a perfusionist and a heart-lung machine in case of device embolization</p>
          </list-item>
        </list>
        <p>For treating both primary MR and secondary MR, the MitraClip device is the first transcatheter technology to get FDA and Conformit&#x000e9; Europ&#x000e9;enne approval.<xref ref-type="bibr" rid="article-179.r49">[49]</xref><xref ref-type="bibr" rid="article-179.r50">[50]</xref>&#x000a0;The fourth-generation MitraClip has 4 implant sizes available in 2 different widths and 2 different arm lengths as of 2020.<xref ref-type="bibr" rid="article-179.r51">[51]</xref>&#x000a0;These include the "traditional" width of 4 mm and the newer 6 mm size. Both widths are available in the NT clip with a 9 mm arm length and the XT clip with a 12 mm arm length.&#x000a0;</p>
        <p>The MitraClip comprises 2 rigid arms of cobalt-chromium alloy featuring flexible nitinol-based "grippers." These grippers are equipped with either 4 (in the case of NT/NTW) or 6 (XT/XTW) small hooks, often referred to as "frictional elements," arranged longitudinally. Notably, the longer clip arms (XT/XTW) extend beyond the strict anatomical and morphological criteria set forth by the EVEREST trials, allowing for the treatment of more extensive coaptation gaps and leaflet flails.<xref ref-type="bibr" rid="article-179.r52">[52]</xref>&#x000a0;</p>
        <p>Expanding the use of XT/XTW devices to patients with more complex anatomies has raised concerns about potential risks, such as leaflet injuries and single leaflet device attachment. These concerns arise from increased leaflet tension resulting from the grasping of more tissue with the XT/XTW devices and the presence of an active locking mechanism and device stiffness. Such increased tension forces have been observed to cause leaflet injury in various anatomical scenarios, including cases with calcified leaflets.<xref ref-type="bibr" rid="article-179.r52">[52]</xref>&#x000a0;</p>
        <p>A comprehensive examination of the EXPAND registry did not reveal higher rates of adverse leaflet events associated with the long-arm XTR clip system compared to the smaller NTR device.<xref ref-type="bibr" rid="article-179.r24">[24]</xref>&#x000a0;The fourth-generation MitraClip device now offers the advantage of autonomous and controlled gripper actuation. This feature allows for the confirmation and optimization of leaflet gripping while enabling continuous left atrial pressure monitoring through the guiding catheter.</p>
        <p>The PASCAL transcatheter mitral valve repair technology was first introduced in 2016 and has since been evaluated in a compassionate-use cohort of 23 patients with challenging anatomical characteristics for transcatheter edge-to-edge repair.<xref ref-type="bibr" rid="article-179.r53">[53]</xref>&#x000a0;The latest iteration of the PASCAL system, its second version, has been released, incorporating three integrated catheters: a 22 Fr steerable guide sheath, a maneuverable catheter, and an implant catheter with the device preattached at the distal end. This innovative design allows for a wide range of motion and enhances maneuverability within the left atrium.</p>
        <p>The PASCAL P10 implant, constructed from nitinol, features a central spacer and two spring-loaded curved paddles, offering a gripping length of 26 mm when opened to 180&#x000b0;, along with 2 clasps (each measuring 10 mm). The central spacer is strategically designed to fill specific coaptation gaps within the primary MR jet area, thus reducing stresses on the mitral valve leaflets. The nitinol clasps possess a horizontal line of small hooks, referred to as "retention elements," at the distal end, which can be adjusted independently. This feature allows for either simultaneous or independent leaflet capture.</p>
        <p>A smaller version (the PASCAL Ace) maintains a gripping breadth comparable to the PASCAL P10 implant. However, the paddles on the PASCAL Ace are only 6 mm wide, making them suitable for smaller anatomies and enabling various implant techniques. Both PASCAL implants offer the flexibility of separate leaflet gripping, allowing for either "leaflet optimization" or "staged leaflet capture."&#x000a0;Notably, in August 2022, the second-generation PASCAL Precision platform was unveiled, featuring enhancements to the catheter system that improve device stability and steerability.<xref ref-type="bibr" rid="article-179.r54">[54]</xref></p>
      </sec>
      <sec id="article-179.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>The key personnel required to adequately and safely perform catheter-based MR treatment with the&#x000a0;TEER device include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Interventional cardiologist</p>
          </list-item>
          <list-item>
            <p>Echocardiographer, either a cardiac anesthesiologist or a cardiologist</p>
          </list-item>
          <list-item>
            <p>Cardiac anesthesiologist</p>
          </list-item>
          <list-item>
            <p>First-assist, for the proceduralist&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Nursing and technical staff for the procedure</p>
          </list-item>
          <list-item>
            <p>Cardiac surgeon and operating room staff, on standby in case of emergent complication</p>
          </list-item>
          <list-item>
            <p>Perfusionist if there is a need for cardiopulmonary bypass</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-179.s8" sec-type="Preparation">
        <title>Preparation</title>
        <p>The TEER procedure is typically performed in a catheterization lab or a hybrid operating room with fluoroscopy capabilities. The procedure also necessitates real-time transthoracic echocardiography, TEE, which is pivotal in confirming the pathology, guiding the procedure, and ensuring repair effectiveness. Given the critical role of TEE, TEER is usually performed under general anesthesia to facilitate TEE evaluation and prevent any accidental patient movement, which could have severe consequences. Before commencing the TEER procedure, preoperative TEE should be conducted to thoroughly assess the mitral valve lesion and evaluate the feasibility of repair. In some cases, it may be necessary to obtain other forms of cardiac imaging performed by a trained cardiovascular interventionalist or cardiovascular imaging specialist.</p>
        <p>Additionally, a preoperative anesthetic evaluation is essential to optimize patients for general anesthesia, ensuring their safety and comfort throughout the procedure. Collaboration among the structural heart team, which comprises key members, including the interventional cardiologist, cardiac anesthesiologist, operating room personnel, and nursing staff, is crucial for the procedure's success. Adequate preparation, including readily available equipment and devices, is paramount. Conducting a preprocedure time-out is recommended to ensure effective communication within the team and confirm that all necessary components are in place.</p>
        <p>Sterility is a critical aspect of preparation for any medical procedure, and this is no exception. Before the procedure, a sterile field is established. The catheter insertion site is thoroughly sterilized in line with standard catheterization protocols. All personnel near the sterile field should follow strict sterile techniques, including scrubbing and wearing full gowns, hats, masks, and gloves. The procedure area should be cleaned and appropriately draped before commencement to maintain a sterile environment and ensure patient safety.<xref ref-type="bibr" rid="article-179.r55">[55]</xref>&#x000a0;</p>
        <p>
<bold>Device Selection</bold>
</p>
        <p>When using 3DE, it is crucial to carefully assess the underlying etiology, baseline mitral valve area, mean transmitral gradient, and anatomical complexity before selecting the appropriate device. The primary criteria to be considered when choosing a device are shown below (see&#x000a0;<bold>Table 6.</bold>&#x000a0;Mitral Valve Criteria for Device Selection).</p>
        <table-wrap id="article-179.table5" position="float" orientation="portrait">
          <caption>
            <title>Table 6. Mitral Valve Criteria for Device Selection</title>
          </caption>
          <table style="height: 401px; width: 750px;" border="1" cellspacing="1" cellpadding="20">
            <tbody>
              <tr>
                <td style="width: 266px;" rowspan="1" colspan="1">Mitral valve anatomy</td>
                <td style="width: 23.2344px;" rowspan="1" colspan="1">NT</td>
                <td style="width: 10px;" rowspan="1" colspan="1">NTW</td>
                <td style="width: 17px;" rowspan="1" colspan="1">XT</td>
                <td style="width: 10px;" rowspan="1" colspan="1">XTW</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">PASCAL P10</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">PASCAL ACE</td>
              </tr>
              <tr>
                <td style="width: 266px;" rowspan="1" colspan="1">Length of the leaflet grasping zone &#x0003c;9 mm</td>
                <td style="width: 23.2344px; text-align: center;" rowspan="1" colspan="1">+</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">+</td>
                <td style="width: 17px; text-align: center;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">+</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td style="width: 266px;" rowspan="1" colspan="1">Length of the leaflet grasping zone &#x0003e;9 mm</td>
                <td style="width: 23.2344px; text-align: center;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 17px; text-align: center;" rowspan="1" colspan="1">+</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">+</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">+</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td style="width: 266px;" rowspan="1" colspan="1">Barlow disease</td>
                <td style="width: 23.2344px; text-align: center;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 17px; text-align: center;" rowspan="1" colspan="1">+</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">+</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">+</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td style="width: 266px;" rowspan="1" colspan="1">Thin leaflet structure</td>
                <td style="width: 23.2344px; text-align: center;" rowspan="1" colspan="1">+</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">+</td>
                <td style="width: 17px; text-align: center;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">+</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">+</td>
              </tr>
              <tr>
                <td style="width: 266px;" rowspan="1" colspan="1">Broad gap size</td>
                <td style="width: 23.2344px; text-align: center;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">+</td>
                <td style="width: 17px; text-align: center;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">+</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">+</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">&#x000a0;</td>
              </tr>
              <tr>
                <td style="width: 266px;" rowspan="1" colspan="1">Commissural jet</td>
                <td style="width: 23.2344px; text-align: center;" rowspan="1" colspan="1">&#x000a0;+</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">&#x000a0;+</td>
                <td style="width: 17px; text-align: center;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">&#x000a0;+</td>
              </tr>
              <tr>
                <td style="width: 266px;" rowspan="1" colspan="1">MV area &#x0003c;4.0 cm<sup>2</sup></td>
                <td style="width: 23.2344px; text-align: center;" rowspan="1" colspan="1">&#x000a0;+</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">&#x000a0;+</td>
                <td style="width: 17px; text-align: center;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 10px; text-align: center;" rowspan="1" colspan="1">&#x000a0;+</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>The accurate quantification of the mitral valve area, MVA, ideally involves multiplanar reconstruction using high-resolution 3D volumes of the mitral valve. When deploying a PASCAL P10 device, the MVA has been observed to be reduced by approximately 47%. However, using rigid implants with extended arms (XTW/XT) is expected to impact the baseline MVA substantially. Specifically, the&#x000a0;MVA reduction achieved with the NTR and XTR implants was 52% and 57%, respectively.<xref ref-type="bibr" rid="article-179.r56">[56]</xref> It's important to note that the extent of&#x000a0;MVA reduction depends on the precise location of the device along the line of coaptation, with the A2/P2 position experiencing the most significant reduction and commissural placement resulting in the least reduction.<xref ref-type="bibr" rid="article-179.r56">[56]</xref></p>
        <p>Two pivotal factors influencing the selection of devices for TMVR are the chosen treatment strategy and the localization of the regurgitant jet. Notably, individuals with discrete jets, in whom the expectation is to implant&#x000a0;2 distant clips to address the issue, necessitate a larger baseline mitral valve area, around 6 cm<sup>2</sup>, to prevent the development of significant&#x000a0;MV stenosis.<xref ref-type="bibr" rid="article-179.r56">[56]</xref></p>
        <p>In cases where significant flail gaps or wide prolapses are present, particularly when multiple implants are required for stabilization, devices with extended arms (XTW, XT, or PASCAL) have shown increased effectiveness in reducing mitral regurgitation.<xref ref-type="bibr" rid="article-179.r57">[57]</xref>&#x000a0;However, when a multiple-clip strategy is considered, using PASCAL P10 is not recommended due to the concave design of its paddles, which may complicate the precise alignment of&#x000a0;2 implants.&#x000a0;For isolated commissural lesions, the preference should be for implants with smaller arms (NTW/NT) and dependable steering capabilities.<xref ref-type="bibr" rid="article-179.r57">[57]</xref></p>
        <p>Conducting a thorough assessment of the length and thickness of the leaflet tissue is essential. When annular calcifications with leaflet infiltration are identified as predictors of a higher transmitral gradient after TEER, opting for smaller, more flexible devices is advisable.<xref ref-type="bibr" rid="article-179.r26">[26]</xref><xref ref-type="bibr" rid="article-179.r58">[58]</xref>&#x000a0;In cases of secondary&#x000a0;MR involving a short or thin tethered posterior leaflet, it is advisable to avoid devices with extended arms, like the MitraClip XT and XTW, to minimize the risk of single leaflet device attachment or leaflet injury. The PASCAL devices, with their flexible nitinol construction and horizontal positioning of the gripping components, are often preferred, especially when dealing with a short posterior leaflet, as they apply gripping force at the leaflet base, often referred to as the "hinge point" with the mitral annulus.<xref ref-type="bibr" rid="article-179.r54">[54]</xref></p>
      </sec>
      <sec id="article-179.s9" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>
<bold>The Edge-to-Edge Leaflet Repair Device</bold>
</p>
        <p>The structural&#x000a0;heart team comprises an interventional cardiologist, cardiac surgeon, cardiac anesthesiologist, and operating room nurse who is required to perform the transcatheter mitral valve repair with the edge-to-edge leaflet repair device. Procedural rooms are specialized with fluoroscopic capability. The procedure involves using fluoroscopic and TEE guidance to image the heart before, during, and after the procedure.<xref ref-type="bibr" rid="article-179.r59">[59]</xref>&#x000a0;The patient will be under general anesthesia&#x000a0;for ease and comfort and to avoid patient movement during the procedure.</p>
        <p>The following table&#x000a0;demonstrates the procedure's major steps; the TEE views to guide those steps, and potential complications with each step (see&#x000a0;<bold>Table 7. </bold>Transcatheter Edge-to-Edge Leaflet Repair&#x000a0;Procedure Overview).&#x000a0;</p>
        <p>&#x000a0;<bold>Table 7.&#x000a0;</bold>Transcatheter Edge-to-Edge Leaflet Repair<bold>&#x000a0;</bold>Procedure Overview</p>
        <table-wrap id="article-179.table6" position="float" orientation="portrait">
          <table style="border-color: black; width: 800px;" border="1" cellspacing="1" cellpadding="5">
            <tbody>
              <tr style="height: 30px;">
                <td style="width: 177.90625px; height: 30px; text-align: center;" rowspan="1" colspan="1">
<bold>Major Steps in the Procedure</bold>
</td>
                <td style="width: 263.453125px; height: 30px; text-align: center;" rowspan="1" colspan="1">
<bold>Things to Consider for a Successful Procedure</bold>
</td>
                <td style="width: 264.640625px; height: 30px; text-align: center;" rowspan="1" colspan="1">
<bold>TEE View&#x000a0;</bold>
</td>
                <td style="width: 96.765625px; height: 30px; text-align: center;" rowspan="1" colspan="1">
<bold>Images&#x000a0;</bold>
</td>
                <td style="width: 124.28125px; height: 30px; text-align: center;" rowspan="1" colspan="1">
<bold>Potential Complications</bold>
</td>
              </tr>
              <tr style="height: 1px;">
                <td style="width: 177.90625px; height: 1px;" rowspan="1" colspan="1">
<p>Preprocedure: Cardiac assessment and evaluation of&#x000a0;MV by TEE&#x000a0;<xref ref-type="bibr" rid="article-179.r60">[60]</xref></p>
</td>
                <td style="width: 263.453125px; height: 1px;" rowspan="1" colspan="1">
<p>The valvular pathology must be confirmed</p>
<p>Intracardiac thrombus must be ruled out before starting the procedure</p>
<p>Favorable echocardiographic features for a successful procedure are as follows:&#x000a0; &#x000a0; &#x000a0;</p>
<list list-type="bullet"><list-item><p>Coaptation length &#x02265;2 mm&#x000a0;</p></list-item><list-item><p>Coaptation depth &#x02264;11 mm.&#x000a0;</p></list-item><list-item><p>Flail gap &#x0003c;10 mm&#x000a0; &#x000a0;</p></list-item><list-item><p>Flail width &#x0003c;15 mm&#x000a0;<xref ref-type="bibr" rid="article-179.r9">[9]</xref>&#x000a0;</p></list-item></list>
</td>
                <td style="width: 264.640625px; height: 1px;" rowspan="1" colspan="1">
<p>4-chamber midesophageal, 2-chamber, modified bicaval, midesophageal&#x000a0;long axis, and&#x000a0;LA appendage-focused views to rule out intracardiac thrombus</p>
<p>Color and pulse wave Doppler of the&#x000a0;LA appendage</p>
<p>Evaluate interatrial&#x000a0;septum anatomy</p>
<p>Determine the baseline MR severity, MR mechanism, Doppler gradients across the MV,&#x000a0;MVA measurement, presence of any pericardial effusion, and pulmonary vein Doppler profile&#x000a0;<xref ref-type="bibr" rid="article-179.r61">[61]</xref></p>
<p>Determine if any pericardial effusions are present before starting the procedure and quantify the effusion.</p>
</td>
                <td style="width: 96.765625px; height: 1px;" rowspan="1" colspan="1">
<p>Mitral Valve, En Face View&#x000a0;</p>
<p>Mitral Valve,&#x000a0;Echocardiograph</p>
<p>Posterior Mitral Leaflet With Flail Central Scallop (P2) Flail</p>
<p>Mitral Valve Prolapse, Echocardiograph</p>
</td>
                <td style="width: 124.28125px; height: 1px;" rowspan="1" colspan="1">None</td>
              </tr>
              <tr style="height: 231px;">
                <td style="width: 177.90625px; height: 231px;" rowspan="1" colspan="1">
<p>Femoral venous access and cannulation</p>
</td>
                <td style="width: 263.453125px; height: 231px;" rowspan="1" colspan="1">
<p>Use ultrasound guidance for femoral venous access</p>
<p>Follow the wire in&#x000a0;under fluoroscopy&#x000a0;to ensure no kinking or malposition&#x000a0;</p>
<p>Assess the size of the vessel to be able to accommodate the catheter and delivery system</p>
<p>Check vein compressibility and the color Doppler to rule out femoral vein thrombus&#x000a0;</p>
<p>Consider a micropuncture kit followed by the sheath and percutaneous suture devices for cannulation</p>
</td>
                <td style="width: 264.640625px; height: 231px;" rowspan="1" colspan="1">
<p>Transgastric IVC views in short and long axes to visualize the wire as it advances into IVC to the&#x000a0;RA</p>
</td>
                <td style="width: 96.765625px; height: 231px;" rowspan="1" colspan="1">Pelvic Veins</td>
                <td style="width: 124.28125px; height: 231px;" rowspan="1" colspan="1">
<p>Bleeding at the vein puncture site</p>
<p>Retroperitoneal hemorrhage</p>
<p>Femoral arterial injury&#x000a0;</p>
<p>Injury to surrounding structures</p>
</td>
              </tr>
              <tr style="height: 361px;">
                <td style="width: 177.90625px; height: 361px;" rowspan="1" colspan="1">
<p>Transseptal puncture&#x000a0;</p>
</td>
                <td style="width: 263.453125px; height: 361px;" rowspan="1" colspan="1">
<p>Septal puncture is performed in the posterior superior portion of the IAS</p>
<p>The tip of the transseptal puncture needle on the&#x000a0;IAS appears like an indentation (tenting)</p>
<p>The tip should point toward the&#x000a0;LA and confirm the anterior-posterior and superior-inferior orientation, as well as the height of the puncture above the mitral annular plane before crossing the septum&#x000a0;</p>
<p>The height of the transeptal puncture should be 4 to 5 cm from the mitral annular plane:</p>
<list list-type="bullet"><list-item><p>A septal puncture that is too low may limit the maneuverability of the&#x000a0;edge-to-edge repair device delivery system, which may lead to adjustments made towards the ventricular side, thus risking chordae entanglement</p></list-item><list-item><p>A septal puncture that is too high can limit the ability of the&#x000a0;edge-to-edge repair device delivery system to pass below leaflets and make leaflet capture difficult.</p></list-item></list>
<p>A transeptal puncture at a higher height is used for medial jets, while a lower height is used for lateral jets&#x000a0;<xref ref-type="bibr" rid="article-179.r62">[62]</xref></p>
<p>De-airing of device delivery system to avoid air embolism &#x000a0;&#x000a0;</p>
<p>Consider a radiofrequency transseptal needle if the septum is very "floppy," fibrotic, or lipomatous</p>
<p>Use real-time TEE monitoring during transseptal puncture to ensure the puncture needle is not directed toward the aorta or posterior LA</p>
<list list-type="bullet"><list-item><p>Consider orthogonal plane imaging and wide sector full-volume view of the LA</p></list-item></list>
<p>Achieve an&#x000a0;ACT &#x0003e;250 to decrease the risk of clot formation. Heparinize and monitor ACT every 15 to 30 min.&#x000a0;</p>
</td>
                <td style="width: 264.640625px; height: 361px;" rowspan="1" colspan="1">
<p>Midesophageal bicaval view to guide transseptal puncture needle into the&#x000a0;RA</p>
<p>Midesophageal bicaval 120&#x000b0;&#x000a0;to obtain&#x000a0;superior-inferior&#x000a0;orientation with tenting of the fossa, ie, superior towards&#x000a0; the SVC, inferior towards&#x000a0;the IVC</p>
<p>The midesophageal aortic valve short axis shows the anterior-posterior portion of the IAS, ie, the anterior part is towards the aorta/aortic valve</p>
<p>4-chamber midesophageal view shows the distance from the point of septal puncture to the mitral annular plane</p>
</td>
                <td style="width: 96.765625px; height: 361px;" rowspan="1" colspan="1">Transseptal Puncture for Mitra Clip Procedure</td>
                <td style="width: 124.28125px; height: 361px;" rowspan="1" colspan="1">&#x000a0;
<p>If a transseptal puncture&#x000a0;is too anterior, it can cause injury to the aortic valve, ascending aorta, and aortic root.&#x000a0;</p>
<p>Cardiac tamponade</p>
<p>Air embolism</p>
</td>
              </tr>
              <tr style="height: 210px;">
                <td style="width: 177.90625px; height: 210px;" rowspan="1" colspan="1">
<p>Insertion of the&#x000a0;SGC</p>
</td>
                <td style="width: 263.453125px; height: 210px;" rowspan="1" colspan="1">
<p>An extra stiff Amplatz wire is placed in the left upper pulmonary vein under TEE, and fluoroscopic guidance, and an&#x000a0;SGC and dilator are advanced over it.&#x000a0;&#x000a0;</p>
<p>The dilator is identified by its cone-shaped tip</p>
<p>The bright radiopaque double-ring echo identifies the SGC</p>
<p>Once the&#x000a0;SGC is placed in the LA, the extra stiff Amplatz wire is retrieved, followed by the dilator</p>
</td>
                <td style="width: 264.640625px; height: 210px;" rowspan="1" colspan="1">Real-time 3D imaging from the aortic valve short axis or mitral commissural views is used to get a 3D assessment of the SGC and delivery system in the LA.</td>
                <td style="width: 96.765625px; height: 210px;" rowspan="1" colspan="1">Mitra Clip Steerable Guide Catheter</td>
                <td style="width: 124.28125px; height: 210px;" rowspan="1" colspan="1">&#x000a0;</td>
              </tr>
              <tr style="height: 328px;">
                <td style="width: 177.90625px; height: 328px;" rowspan="1" colspan="1">
<p>Introduction of the&#x000a0;edge-to-edge repair device&#x000a0;clip delivery system&#x000a0;into the LA</p>
</td>
                <td style="width: 263.453125px; height: 328px;" rowspan="1" colspan="1">
<p>The edge-to-edge repair device delivery system is advanced through the steerable guide catheter under TEE and fluoroscopic guidance&#x000a0;<xref ref-type="bibr" rid="article-179.r63">[63]</xref></p>
<p>To position the&#x000a0;edge-to-edge repair device delivery system above the MV, posterior torque on SGC and medial deflection of the&#x000a0;edge-to-edge repair device delivery system with retraction of the whole system is required.</p>
<p>Edge-to-edge repair device alignment and adjustments are monitored medial-lateral and anterior-posterior under TEE and fluoroscopic guidance.</p>
<p>Direct the tip of the edge-to-edge&#x000a0;repair device towards the largest regurgitant area.&#x000a0;</p>
</td>
                <td style="width: 264.640625px; height: 328px;" rowspan="1" colspan="1">
<p>Real-time 3D imaging from the aortic valve short axis or mitral commissural views is used to get a 3D&#x000a0;assessment of the&#x000a0;SGC&#x000a0;and delivery system in the&#x000a0;LA.</p>
</td>
                <td style="width: 96.765625px; height: 328px;" rowspan="1" colspan="1">
<p>Transcatheter Edge-to-Edge Valve Repair Device</p>
<p>MitraClip Delivery System&#x000a0;</p>
</td>
                <td style="width: 124.28125px; height: 328px;" rowspan="1" colspan="1">&#x000a0;</td>
              </tr>
              <tr style="height: 229px;">
                <td style="width: 177.90625px; height: 229px;" rowspan="1" colspan="1">Axial alignment of the edge-to-edge repair device&#x000a0;clip delivery system</td>
                <td style="width: 263.453125px; height: 229px;" rowspan="1" colspan="1">The guide catheter is advanced into the LA oriented perpendicular to the coaptation line of the MV</td>
                <td style="width: 264.640625px; height: 229px;" rowspan="1" colspan="1">
<p>The midesophageal mitral commissural view&#x000a0;shows medial and lateral orientation on&#x000a0;the MV.</p>
<p>The midesophageal long-axis&#x000a0;view shows anteroposterior orientation on&#x000a0;the MV.</p>
<p>3D&#x000a0;en face view of the&#x000a0;MV&#x000a0;helps guide the edge-to-edge repair device delivery system and orient it to the MR jet.</p>
<p>A real-time 3D en face view can help guide the trajectory and motion of the edge-to-edge repair device delivery system from the&#x000a0;LA through the&#x000a0;MV into the LV.</p>
</td>
                <td style="width: 96.765625px; height: 229px;" rowspan="1" colspan="1">
<p>Mitral Valve, En Face View&#x000a0;</p>
<p>Device Orientation in Percutaneous Mitral Valve Repair</p>
</td>
                <td style="width: 124.28125px; height: 229px;" rowspan="1" colspan="1">
<p>Arrhythmias</p>
<p>Atrial wall injury</p>
<p>Cardiac tamponade</p>
<p>Injury to&#x000a0;MV apparatus and surrounding structures</p>
<p>Air embolism</p>
</td>
              </tr>
              <tr style="height: 272px;">
                <td style="width: 177.90625px; height: 272px;" rowspan="1" colspan="1">Advancement of the device into the&#x000a0;LV and leaflet grasping&#x000a0;</td>
                <td style="width: 263.453125px; height: 272px;" rowspan="1" colspan="1">
<p>To avoid injury, the device should be continuously visualized, especially the delivery system's tip</p>
<p>The delivery device should be perpendicular to the&#x000a0;MV's regurgitant orifice and coaptation line</p>
<p>Confirm the position in relation to the regurgitant jet and&#x000a0;MV leaflets as the delivery system and device enter the LV</p>
<p>Ensure no entanglement exists in the subvalvular&#x000a0;MV apparatus and chordae tendineae</p>
<p>Rapid pacing or ventilation holding may be needed to make the procedure more precise</p>
</td>
                <td style="width: 264.640625px; height: 272px;" rowspan="1" colspan="1">
<p>3D en face view of the MV, looking from the&#x000a0;LA and LV&#x000a0;perspectives</p>
<p>Biplane imaging of midesophageal mitral commissural view and midesophageal&#x000a0;long axis view, with and without color Doppler, can be used to evaluate the orientation of&#x000a0;MV's anterior and posterior leaflets to the edge-to-edge repair device arms.</p>
<p>Fluoroscopy can be used to aid orientation along with TEE.</p>
</td>
                <td style="width: 96.765625px; height: 272px;" rowspan="1" colspan="1">
<p>Mitral Valve, En Face View&#x000a0;</p>
<p>MitraClip Delivery System&#x000a0;</p>
<p>Mitral Valve Leaflet Grasping&#x000a0;</p>
</td>
                <td style="width: 124.28125px; height: 272px;" rowspan="1" colspan="1">
<p>Arrhythmias</p>
<p>Injury to the MV</p>
<p>Entanglement of the device delivery system and the device in subvalvular apparatus</p>
</td>
              </tr>
              <tr style="height: 348px;">
                <td style="width: 177.90625px; height: 348px;" rowspan="1" colspan="1">Assessment of leaflet capture and&#x000a0;edge-to-edge repair device deployment</td>
                <td style="width: 263.453125px; height: 348px;" rowspan="1" colspan="1">
<p>Integrate echo and fluoroscopic images</p>
<p>Orient the device before entering the LV and avoid too much manipulation, as it can lead to&#x000a0;edge-to-edge repair device entanglement and injury to the subvalvular apparatus</p>
<p>Consider rapid ventricular pacing or holding mechanical ventilation to decrease motion and achieve a better leaflet grasp&#x000a0;<xref ref-type="bibr" rid="article-179.r43">[43]</xref></p>
<p>If the coaptation defect width is significant,&#x000a0; consider using the "zip and clip" technique, where the first&#x000a0;edge-to-edge repair device can be deployed immediately medial or lateral to the largest coaptation defect and thus facilitate leaflet grip in the area of bigger coaptation defect.&#x000a0;</p>
<p>Monitor for spontaneous echo contrast and monitor ACT to ensure no thrombus formation in the LA.&#x000a0;</p>
</td>
                <td style="width: 264.640625px; height: 348px;" rowspan="1" colspan="1">
<p>Obtaining a&#x000a0;2D midesophageal mitral commissural view and a long axis view simultaneously&#x000a0;allows for visualization of the length of leaflets within the edge-to-edge repair device arms and restriction of leaflet motion with edge-to-edge repair device grasping the leaflets.</p>
<p>Fluoroscopy is used to confirm the position and stability of the device.</p>
</td>
                <td style="width: 96.765625px; height: 348px;" rowspan="1" colspan="1">&#x000a0;None</td>
                <td style="width: 124.28125px; height: 348px;" rowspan="1" colspan="1">
<p>Edge-to-edge repair device detachment</p>
<p>Injury to&#x000a0;MV apparatus</p>
<p>MV leaflet injury causing severe MR not amenable to percutaneous repair</p>
<p>Mitral stenosis&#x000a0;</p>
</td>
              </tr>
              <tr style="height: 144px;">
                <td style="width: 177.90625px; height: 144px;" rowspan="1" colspan="1">Assessment after edge-to-edge repair device deployment&#x000a0;</td>
                <td style="width: 263.453125px; height: 144px;" rowspan="1" colspan="1">
<p>Assess for any complications</p>
<p>Assess for the stability of leaflet capture and the device</p>
<p>Assess for residual MR, mitral stenosis, and&#x000a0;edge-to-edge repair device dislodgement&#x000a0;</p>
<p>The transmitral&#x000a0;gradient should be &#x0003c;5 mm Hg</p>
</td>
                <td style="width: 264.640625px; height: 144px;" rowspan="1" colspan="1">
<p>Simultaneous assessment of the 2D midesophageal commissural view and the long-axis view</p>
<p>3D en face view from the perspective of both&#x000a0;the LA and LV&#x000a0;</p>
<p>Doppler assessment of the gradient at the MV&#x000a0;after deployment of edge-to-edge repair device</p>
</td>
                <td style="width: 96.765625px; height: 144px;" rowspan="1" colspan="1">Mitral Valve Repair, Edge-to-Edge Percutaneous Device</td>
                <td style="width: 124.28125px; height: 144px;" rowspan="1" colspan="1">
<p>Leaflet injury</p>
<p>Leaflet perforation</p>
<p>Creation of mitral stenosis</p>
<p>Injury to subvalvular mitral apparatus</p>
<p>Residual MR necessitates the placement of an additional edge-to-edge repair device.</p>
</td>
              </tr>
              <tr style="height: 344px;">
                <td style="width: 177.90625px; height: 344px;" rowspan="1" colspan="1">Withdrawal of the&#x000a0;edge-to-edge repair device delivery system and&#x000a0;SGC from the patient&#x000a0;</td>
                <td style="width: 263.453125px; height: 344px;" rowspan="1" colspan="1">
<p>Evaluate for iatrogenic&#x000a0;ASD</p>
<p>Reverse heparin with protamine to avoid bleeding and help with hemostasis</p>
<p>Monitor for protamine reaction</p>
<p>Monitor femoral venous sites for bleeding</p>
<p>A complete postprocedure echocardiographic evaluation should be done to assess the repair and rule out complications</p>
</td>
                <td style="width: 264.640625px; height: 344px;" rowspan="1" colspan="1">
<p>4-chamber midesophageal view, midesophageal commissural view, midesophageal long axis view, all with and without color Doppler</p>
<p>Midesophageal view assessing pulmonary venous flow to assess the reduction in MR</p>
<p>Continuous wave Doppler assessment of&#x000a0;MV to assess for mitral stenosis&#x000a0;</p>
<p>The 3D en face view of the repaired&#x000a0;MV from the LA and LV view ensures leaflet grip and device stability</p>
<p>3D reconstruction and multiplanar reconstruction to assess the area of the repaired double orifice MV&#x000a0;<xref ref-type="bibr" rid="article-179.r64">[64]</xref><xref ref-type="bibr" rid="article-179.r65">[65]</xref></p>
<p>Midesophageal bicaval view and 3D imaging of IAS to assess for iatrogenic ASD&#x000a0;<xref ref-type="bibr" rid="article-179.r66">[66]</xref></p>
</td>
                <td style="width: 96.765625px; height: 344px;" rowspan="1" colspan="1">
<p>Mitral Valve Repair, Edge-to-Edge Percutaneous Device</p>
<p>Iatrogenic Atrial Septal Defect</p>
</td>
                <td style="width: 124.28125px; height: 344px;" rowspan="1" colspan="1">
<p>Cardiac tamponade</p>
<p>Iatrogenic ASD</p>
<p>Injury to IVC or femoral veins</p>
<p>Protamine reaction</p>
</td>
              </tr>
              <tr style="height: 158px;">
                <td style="width: 177.90625px; height: 158px;" rowspan="1" colspan="1">Postprocedural monitoring&#x000a0;</td>
                <td style="width: 263.453125px; height: 158px;" rowspan="1" colspan="1">Monitoring for postprocedural complications should be done in&#x000a0;the PACU or ICU.</td>
                <td style="width: 264.640625px; height: 158px;" rowspan="1" colspan="1">&#x000a0;None</td>
                <td style="width: 96.765625px; height: 158px;" rowspan="1" colspan="1">&#x000a0;None</td>
                <td style="width: 124.28125px; height: 158px;" rowspan="1" colspan="1">
<p>Respiratory issues</p>
<p>Postoperative nausea and vomiting</p>
<p>Hemodynamic instability</p>
<p>Cardiac tamponade</p>
<p>Bleeding from the femoral site</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>IVC, inferior vena cava; LA, left atrium; LV, left ventricle; RA, right atrium; IAS, interatrial septum; SVC, superior vena cava;&#x000a0;ACT, activated clotting time; SGC, steerable guide catheter; ASD, atrial septal defect; PACU, post-anesthesia care unit; ICU, intensive care unit; MV, mitral valve; IAS, iatrogenic atrial septa; TEER, transcatheter edge-to-edge repair; MR, mitral regurgitation; TEE,&#x000a0;transesophageal echocardiography</p>
      </sec>
      <sec id="article-179.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Despite the significant comorbidities among the patients being treated, TEER is a safe operation with a low likelihood of major consequences. The table below&#x000a0;summarizes the most common complications and their relative occurrence rates (see <bold>Table 8.</bold>&#x000a0;TEER Complications).</p>
        <table-wrap id="article-179.table7" position="float" orientation="portrait">
          <caption>
            <title>Table 8&#x000a0;TEER Complications</title>
          </caption>
          <table style="border-color: black; width: 795px; height: 0px;" border="1" cellspacing="1" cellpadding="5">
            <tbody>
              <tr>
                <td style="width: 413px; text-align: center;" rowspan="1" colspan="1">
<bold>Complication</bold>
</td>
                <td style="width: 222px; text-align: center;" rowspan="1" colspan="1">
<bold>Rate of Complication</bold>
</td>
                <td style="width: 56.7734px; text-align: center;" rowspan="1" colspan="1">
<bold>References</bold>
</td>
              </tr>
              <tr>
                <td style="width: 413px;" rowspan="1" colspan="1">Single leaflet device attachment</td>
                <td style="width: 222px; text-align: center;" rowspan="1" colspan="1">1.5%-5.1%</td>
                <td style="width: 56.7734px; text-align: center;" rowspan="1" colspan="1">
<xref ref-type="bibr" rid="article-179.r11">[11]</xref>
<xref ref-type="bibr" rid="article-179.r67">[67]</xref>
</td>
              </tr>
              <tr>
                <td style="width: 413px;" rowspan="1" colspan="1">Injury to the&#x000a0;MV leaflet</td>
                <td style="width: 222px; text-align: center;" rowspan="1" colspan="1">0%-2%</td>
                <td style="width: 56.7734px; text-align: center;" rowspan="1" colspan="1">
<xref ref-type="bibr" rid="article-179.r51">[51]</xref>
<xref ref-type="bibr" rid="article-179.r52">[52]</xref>
</td>
              </tr>
              <tr>
                <td style="width: 413px;" rowspan="1" colspan="1">Device embolization</td>
                <td style="width: 222px; text-align: center;" rowspan="1" colspan="1">0.05%-0.7%</td>
                <td style="width: 56.7734px; text-align: center;" rowspan="1" colspan="1">&#x000a0;<xref ref-type="bibr" rid="article-179.r11">[11]</xref><xref ref-type="bibr" rid="article-179.r68">[68]</xref></td>
              </tr>
              <tr>
                <td style="width: 413px;" rowspan="1" colspan="1">Transmitral gradient &#x0003e;5 mmHg</td>
                <td style="width: 222px; text-align: center;" rowspan="1" colspan="1">Up to 15%</td>
                <td style="width: 56.7734px; text-align: center;" rowspan="1" colspan="1">&#x000a0;<xref ref-type="bibr" rid="article-179.r52">[52]</xref></td>
              </tr>
              <tr>
                <td style="width: 413px;" rowspan="1" colspan="1">Residual&#x000a0;MR &#x0003e;2+</td>
                <td style="width: 222px; text-align: center;" rowspan="1" colspan="1">3.4%-17.0%</td>
                <td style="width: 56.7734px; text-align: center;" rowspan="1" colspan="1"><xref ref-type="bibr" rid="article-179.r51">[51]</xref>&#x000a0;<xref ref-type="bibr" rid="article-179.r52">[52]</xref></td>
              </tr>
              <tr>
                <td style="width: 413px;" rowspan="1" colspan="1">Pericardial effusion or tamponade</td>
                <td style="width: 222px; text-align: center;" rowspan="1" colspan="1">0%-0.5%</td>
                <td style="width: 56.7734px; text-align: center;" rowspan="1" colspan="1">&#x000a0;<xref ref-type="bibr" rid="article-179.r69">[69]</xref></td>
              </tr>
              <tr>
                <td style="width: 413px;" rowspan="1" colspan="1">Major vascular complications</td>
                <td style="width: 222px; text-align: center;" rowspan="1" colspan="1">1.4%-4.0%</td>
                <td style="width: 56.7734px; text-align: center;" rowspan="1" colspan="1">&#x000a0;<xref ref-type="bibr" rid="article-179.r69">[69]</xref></td>
              </tr>
              <tr>
                <td style="width: 413px;" rowspan="1" colspan="1">Severe bleeding requiring blood transfusion</td>
                <td style="width: 222px; text-align: center;" rowspan="1" colspan="1">0%-17%</td>
                <td style="width: 56.7734px; text-align: center;" rowspan="1" colspan="1">&#x000a0;<xref ref-type="bibr" rid="article-179.r69">[69]</xref></td>
              </tr>
              <tr>
                <td style="width: 413px;" rowspan="1" colspan="1">Stroke</td>
                <td style="width: 222px; text-align: center;" rowspan="1" colspan="1">0%-1%</td>
                <td style="width: 56.7734px; text-align: center;" rowspan="1" colspan="1">&#x000a0;<xref ref-type="bibr" rid="article-179.r69">[69]</xref></td>
              </tr>
              <tr>
                <td style="width: 413px;" rowspan="1" colspan="1">Myocardial infarction</td>
                <td style="width: 222px; text-align: center;" rowspan="1" colspan="1">&#x000a0;0%-3%</td>
                <td style="width: 56.7734px; text-align: center;" rowspan="1" colspan="1">&#x000a0;<xref ref-type="bibr" rid="article-179.r69">[69]</xref></td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>The heightened leaflet perforation, tear, or single leaflet device attachment risk in patients with long-standing secondary MR and calcified leaflets raises significant concerns. The percutaneous retrieval of embolized devices can pose challenges, particularly when larger clips are involved.<xref ref-type="bibr" rid="article-179.r70">[70]</xref>&#x000a0;While afterload mismatch may occur in individuals with reduced left ventricle function, it is an infrequent and transient event typically managed with inotropic medications, often not necessitating mechanical support. Despite its rarity, afterload mismatch may adversely impact long-term outcomes, possibly indicating an advanced stage of heart failure. In some cases of secondary MR with severely impaired left ventricle function, thrombus development in the left atrium or ventricle may occur. Early and intensive anticoagulant therapy may be deemed necessary for these patients.<xref ref-type="bibr" rid="article-179.r71">[71]</xref></p>
        <p>The multidisciplinary team must reassess the indication for mitral valve surgery or reintervention when confronted with residual or recurrent MR. A repeat transesophageal echocardiography is typically warranted to comprehend the underlying disease, identify residual leaflet anatomy for potential device implantation, and assess the risk of significant mitral stenosis. In case series with limited safety data, alternative interventional strategies for managing substantial para-clip or inter-clip residual MR have been explored. Examples include using an Amplatzer vascular plug (Abbott), originally designed for peripheral vasculature embolization, or an enlarged polytetrafluoroethylene double-disk occluder, initially intended for closing atrial septal defects.<xref ref-type="bibr" rid="article-179.r38">[38]</xref><xref ref-type="bibr" rid="article-179.r72">[72]</xref></p>
        <p>According to a large multicenter registry, implant failure due to leaflet perforation, tear, or loss affects 3.5% of patients and is associated with increased in-hospital and long-term mortality.<xref ref-type="bibr" rid="article-179.r73">[73]</xref>&#x000a0;Redo TEER is a viable option and may be preferable to surgery in anatomically suitable patients with primary or secondary MR, especially when surgical outcomes are suboptimal.<xref ref-type="bibr" rid="article-179.r74">[74]</xref></p>
      </sec>
      <sec id="article-179.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Catheter management of MR represents a significant recent innovation, marking a considerable advancement in cardiology; it provides a corrective option for patients with severe MR and high surgical risks. Recent studies indicate that catheter management may, in certain circumstances, outperform surgical intervention.<xref ref-type="bibr" rid="article-179.r20">[20]</xref></p>
        <p>Following mitral valve repair with the edge-to-edge device, left ventricle contractility and cardiac output remain stable, although total ejection fraction and global strain may decrease. This decline is likely attributable to a reduced regurgitant volume postrepair, leading to decreased left ventricular end-diastolic volume. This reduction in myocardial oxygen demand can contribute to an improved New York Heart Association functional class after 3 months.<xref ref-type="bibr" rid="article-179.r75">[75]</xref></p>
      </sec>
      <sec id="article-179.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Catheter management of mitral valve regurgitation demands a comprehensive approach from an interprofessional team to ensure patient-centered care, optimize outcomes, enhance patient safety, and improve team performance. Physicians, advanced practitioners, nurses, pharmacists, and other health professionals play pivotal roles in various aspects of this procedure. Physicians, particularly highly trained cardiovascular interventionalists, lead the procedural aspects. They collaborate with advanced practitioners to ensure thorough patient assessments and communicate risks and benefits effectively.</p>
        <p>Nurses specializing in cardiology are essential for preoperative, operative, and postoperative monitoring, patient education, and coordination of follow-up care. Interprofessional communication is facilitated by cardiovascular imaging specialists, structuralists, and anesthesiologists who contribute their expertise in optimizing lung and heart function, providing specialized imaging, and ensuring the patient's readiness for anesthesia.</p>
        <p>Pharmacists are crucial for pharmaceutical consultation, addressing postoperative pain management, antiemetics, and blood thinners. This multidisciplinary approach, driven by effective communication and care coordination, is vital for a successful catheter management procedure. Emphasizing this interprofessional collaboration enhances patient safety, improves outcomes, and contributes to overall team performance in the complex landscape of mitral valve regurgitation interventions.</p>
      </sec>
      <sec id="article-179.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=179&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=179">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/179/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=179">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-179.s14">
        <fig id="article-179.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Pelvic Veins.&#x000a0;Pelvic veins include the inferior vena cava, internal iliac vein, common iliac vein, external iliac vein, femoral vein, deep circumflex iliac vein, middle sacral vein, and lateral sacral vein. Henry Vandyke Carter, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://commons.wikimedia.org/w/index.php?search=henry+vandyke&#x00026;title=Special:MediaSearch&#x00026;go=Go&#x00026;type=image">Public Domain</ext-link>, via Wikimedia Commons</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Gray586" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-179.s15">
        <fig id="article-179.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Mitral Valve Anatomy. The mitral&#x000a0;valve anatomy includes the anterior and posterior leaflets and the interior and posterior annulus. Contributed by&#x000a0;S Bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mitral__valve1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-179.s16">
        <fig id="article-179.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Mitral Valve, Transverse View. The image shows the anatomy of the mitral valve. Contributed by&#x000a0;S Bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mitral__valve__2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-179.s17">
        <fig id="article-179.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Mitral Valve, En Face View. The 3D transesophageal echocardiograph shows an en face view of the mitral valve with the anterolateral and posteromedial commissure and aorto mitral curtain. Contributed by V Bora, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Mitral__valve__labelled" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-179.s18">
        <fig id="article-179.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Transseptal Puncture for MitraClip Procedure.&#x000a0;The image&#x000a0;shows the mid esophageal (bicaval) and aortoc valve short axis views of a transseptal puncture during a MitraClip procedure. Contributed by V Bora, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Trans__septal__Puncture__" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-179.s19">
        <fig id="article-179.image.f6" position="float" orientation="portrait">
          <caption>
            <p>Device Orientation in Percutaneous Mitral Valve Repair.&#x000a0;View of&#x000a0;the clip delivery system and device crossing the mitral valve during a repair procedure. Contributed by V Bora, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Clip__delivery__" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-179.s20">
        <fig id="article-179.image.f7" position="float" orientation="portrait">
          <caption>
            <p>MitraClip and Steerable Guide Catheter. A radiograph demonstrates the MitraClip steerable guided catheter in a mitral-valve repair procedure. Contributed by V Bora, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Steerable__guide__catheter__Mitra__clip__" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-179.s21">
        <fig id="article-179.image.f8" position="float" orientation="portrait">
          <caption>
            <p>Transcatheter Edge-to-Edge Valve Repair Device. The&#x000a0;view of a mitral valve edge-to-edge repair device with fluoroscopic guidance. Contributed by V Bora, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Fluro__Mitra__clip__" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-179.s22">
        <fig id="article-179.image.f9" position="float" orientation="portrait">
          <caption>
            <p>Mitral Valve Repair, Edge-to-Edge Percutaneous Device. The image demonstrates the device grasping the mitral valve leaflets, resulting in a double orifice. Contributed by V Bora, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Double__oriface__post__repair__" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-179.s23">
        <fig id="article-179.image.f10" position="float" orientation="portrait">
          <caption>
            <p>Iatrogenic Atrial Septal Defect. The image shows the posttranscatheter edge-to-edge valve repair. Contributed by&#x000a0;V Bora,&#x000a0;MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Iatrogenic__ASD__" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-179.s24">
        <fig id="article-179.image.f11" position="float" orientation="portrait">
          <caption>
            <p>MitraClip Delivery System. The MitraClip delivery system is being advanced by the steerable guide sheath. Contributed by V Bora, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Clip__delivery__system__via__sheath" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-179.s25">
        <fig id="article-179.image.f12" position="float" orientation="portrait">
          <caption>
            <p>Mitral Valve Leaflet Grasping. The image shows a transcatheter edge-to-edge valve repair device grasping mitral valve leaflet. Contributed by V Bora, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Mitral__Valve__Leaflet__grasping__view__" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-179.s26">
        <fig id="article-179.image.f13" position="float" orientation="portrait">
          <caption>
            <p>&#x000a0;Mitral Valve, Echocardiograph.&#x000a0;A color Doppler echocardiogaph demonstrating the mitral valve. Contributed by I Ahmed</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Color__Doppler__Imaging" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-179.s27">
        <fig id="article-179.image.f14" position="float" orientation="portrait">
          <caption>
            <p>Posterior Mitral Leaflet With Flail Central Scallop (P2) Flail. The images&#x000a0;demonstrate 120&#x000b0; (right), 90&#x000b0; (center), and 60&#x000b0; (left) views of the posterior mitral leaflet. Contributed by I Ahmed</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Flail__Mitral__Valve" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-179.s28">
        <fig id="article-179.image.f15" position="float" orientation="portrait">
          <caption>
            <p>Mitral Valve Prolapse.&#x000a0;The&#x000a0;echocardiograph&#x000a0;reveals a mitral valve prolapse. Contributed by I Ahmed</p>
          </caption>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Mitral__Valve__Prolapse.__mp4.mp4" mime-subtype="mp4" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-179.s29">
        <title>References</title>
        <ref id="article-179.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iung</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Baron</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Butchart</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Delahaye</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gohlke-B&#x000e4;rwolf</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Levang</surname>
                <given-names>OW</given-names>
              </name>
              <name>
                <surname>Tornos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vanoverschelde</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Vermeer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Boersma</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ravaud</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vahanian</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.</article-title>
            <source>Eur Heart J</source>
            <year>2003</year>
            <month>Jul</month>
            <volume>24</volume>
            <issue>13</issue>
            <fpage>1231</fpage>
            <page-range>1231-43</page-range>
            <pub-id pub-id-type="pmid">12831818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quader</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rigolin</surname>
                <given-names>VH</given-names>
              </name>
            </person-group>
            <article-title>Two and three dimensional echocardiography for pre-operative assessment of mitral valve regurgitation.</article-title>
            <source>Cardiovasc Ultrasound</source>
            <year>2014</year>
            <month>Oct</month>
            <day>25</day>
            <volume>12</volume>
            <fpage>42</fpage>
            <pub-id pub-id-type="pmid">25344779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Writing Committee Members</collab>
              <name>
                <surname>Otto</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Bonow</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Carabello</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Erwin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Gentile</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jneid</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Krieger</surname>
                <given-names>EV</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Rigolin</surname>
                <given-names>VH</given-names>
              </name>
              <name>
                <surname>Sundt</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Toly</surname>
                <given-names>C</given-names>
              </name>
              <collab>ACC/AHA Joint Committee Members</collab>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Beckman</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Al-Khatib</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Armbruster</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Birtcher</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Ciggaroa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Deswal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dixon</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Fleisher</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>de las Fuentes</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gentile</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Goldberger</surname>
                <given-names>ZD</given-names>
              </name>
              <name>
                <surname>Gorenek</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Haynes</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hernandez</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Hlatky</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Joglar</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Marine</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Mark</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Palaniappan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Piano</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Spatz</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Tamis-Holland</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wijeysundera</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>YJ</given-names>
              </name>
            </person-group>
            <article-title>2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>162</volume>
            <issue>2</issue>
            <fpage>e183</fpage>
            <page-range>e183-e353</page-range>
            <pub-id pub-id-type="pmid">33972115</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guarracino</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Baldassarri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ferro</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Giannini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bertini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Petronio</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Di Bello</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Landoni</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Alfieri</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Transesophageal echocardiography during MitraClip&#x000ae; procedure.</article-title>
            <source>Anesth Analg</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>118</volume>
            <issue>6</issue>
            <fpage>1188</fpage>
            <page-range>1188-96</page-range>
            <pub-id pub-id-type="pmid">24842173</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vahanian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Beyersdorf</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Praz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Milojevic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Baldus</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bauersachs</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Capodanno</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Conradi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>De Bonis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Paulis</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Delgado</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Freemantle</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gilard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Haugaa</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Jeppsson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>J&#x000fc;ni</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pierard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Prendergast</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>S&#x000e1;daba</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Tribouilloy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wojakowski</surname>
                <given-names>W</given-names>
              </name>
              <collab>ESC/EACTS Scientific Document Group</collab>
            </person-group>
            <article-title>2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).</article-title>
            <source>Rev Esp Cardiol (Engl Ed)</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>75</volume>
            <issue>6</issue>
            <fpage>524</fpage>
            <pub-id pub-id-type="pmid">35636831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kang</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Rim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Yun</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation.</article-title>
            <source>Circulation</source>
            <year>2009</year>
            <month>Feb</month>
            <day>17</day>
            <volume>119</volume>
            <issue>6</issue>
            <fpage>797</fpage>
            <page-range>797-804</page-range>
            <pub-id pub-id-type="pmid">19188506</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sidebotham</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Gerber</surname>
                <given-names>IL</given-names>
              </name>
              <name>
                <surname>Fayers</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Intraoperative transesophageal echocardiography for surgical repair of mitral regurgitation.</article-title>
            <source>J Am Soc Echocardiogr</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>345</fpage>
            <page-range>345-66</page-range>
            <pub-id pub-id-type="pmid">24534653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonow</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Badhwar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bavaria</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Elmariah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hung</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Lindenfeld</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Satpathy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Whisenant</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>YJ</given-names>
              </name>
            </person-group>
            <article-title>2020 Focused Update of the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral&#x000a0;Regurgitation: A Report of the American College of Cardiology Solution Set Oversight Committee.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2020</year>
            <month>May</month>
            <day>05</day>
            <volume>75</volume>
            <issue>17</issue>
            <fpage>2236</fpage>
            <page-range>2236-2270</page-range>
            <pub-id pub-id-type="pmid">32068084</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feldman</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rinaldi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fail</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hermiller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Smalling</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Whitlow</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Low</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Herrmann</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Glower</surname>
                <given-names>D</given-names>
              </name>
              <collab>EVEREST Investigators</collab>
            </person-group>
            <article-title>Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2009</year>
            <month>Aug</month>
            <day>18</day>
            <volume>54</volume>
            <issue>8</issue>
            <fpage>686</fpage>
            <page-range>686-94</page-range>
            <pub-id pub-id-type="pmid">19679246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feldman</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Elmariah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Smart</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Trento</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Apruzzese</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fail</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rinaldi</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Smalling</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Hermiller</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Heimansohn</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Grayburn</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Ailawadi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Herrmann</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Acker</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Silvestry</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Glower</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Mauri</surname>
                <given-names>L</given-names>
              </name>
              <collab>EVEREST II Investigators</collab>
            </person-group>
            <article-title>Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2015</year>
            <month>Dec</month>
            <day>29</day>
            <volume>66</volume>
            <issue>25</issue>
            <fpage>2844</fpage>
            <page-range>2844-2854</page-range>
            <pub-id pub-id-type="pmid">26718672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feldman</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Foster</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Glower</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Kar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rinaldi</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Fail</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Smalling</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Engeron</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Loghin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Trento</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Skipper</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Fudge</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Letsou</surname>
                <given-names>GV</given-names>
              </name>
              <name>
                <surname>Massaro</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Mauri</surname>
                <given-names>L</given-names>
              </name>
              <collab>EVEREST II Investigators</collab>
            </person-group>
            <article-title>Percutaneous repair or surgery for mitral regurgitation.</article-title>
            <source>N Engl J Med</source>
            <year>2011</year>
            <month>Apr</month>
            <day>14</day>
            <volume>364</volume>
            <issue>15</issue>
            <fpage>1395</fpage>
            <page-range>1395-406</page-range>
            <pub-id pub-id-type="pmid">21463154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alfieri</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Maisano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>De Bonis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stefano</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Torracca</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Oppizzi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>La Canna</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The double-orifice technique in mitral valve repair: a simple solution for complex problems.</article-title>
            <source>J Thorac Cardiovasc Surg</source>
            <year>2001</year>
            <month>Oct</month>
            <volume>122</volume>
            <issue>4</issue>
            <fpage>674</fpage>
            <page-range>674-81</page-range>
            <pub-id pub-id-type="pmid">11581597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mack</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Lindenfeld</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Kar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Mishell</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Whisenant</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Grayburn</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Rinaldi</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kapadia</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Rajagopal</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sarembock</surname>
                <given-names>IJ</given-names>
              </name>
              <name>
                <surname>Brieke</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Marx</surname>
                <given-names>SO</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Weissman</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>GW</given-names>
              </name>
              <collab>COAPT Investigators</collab>
            </person-group>
            <article-title>3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart&#x000a0;Failure.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2021</year>
            <month>Mar</month>
            <day>02</day>
            <volume>77</volume>
            <issue>8</issue>
            <fpage>1029</fpage>
            <page-range>1029-1040</page-range>
            <pub-id pub-id-type="pmid">33632476</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khatib</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Neuburger</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rong</surname>
                <given-names>LQ</given-names>
              </name>
            </person-group>
            <article-title>Transcatheter Mitral Valve Interventions for Mitral Regurgitation: A Review of Mitral Annuloplasty, Valve Replacement, and Chordal Repair Devices.</article-title>
            <source>J Cardiothorac Vasc Anesth</source>
            <year>2022</year>
            <month>Oct</month>
            <volume>36</volume>
            <issue>10</issue>
            <fpage>3887</fpage>
            <page-range>3887-3903</page-range>
            <pub-id pub-id-type="pmid">35871885</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Backer</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Piazza</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Banai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lutter</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Maisano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Herrmann</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Franzen</surname>
                <given-names>OW</given-names>
              </name>
              <name>
                <surname>S&#x000f8;ndergaard</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous transcatheter mitral valve replacement: an overview of devices in preclinical and early clinical evaluation.</article-title>
            <source>Circ Cardiovasc Interv</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>400</fpage>
            <page-range>400-9</page-range>
            <pub-id pub-id-type="pmid">24944303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ooms</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Van Mieghem</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Transcatheter Repair and Replacement Technologies for Mitral Regurgitation: a European Perspective.</article-title>
            <source>Curr Cardiol Rep</source>
            <year>2021</year>
            <month>Jul</month>
            <day>16</day>
            <volume>23</volume>
            <issue>9</issue>
            <fpage>125</fpage>
            <pub-id pub-id-type="pmid">34269914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Condado</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>V&#x000e9;lez-Gim&#x000f3;n</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Catheter-based approach to mitral regurgitation.</article-title>
            <source>J Interv Cardiol</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>16</volume>
            <issue>6</issue>
            <fpage>523</fpage>
            <page-range>523-34</page-range>
            <pub-id pub-id-type="pmid">14632950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perloff</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>WC</given-names>
              </name>
            </person-group>
            <article-title>The mitral apparatus. Functional anatomy of mitral regurgitation.</article-title>
            <source>Circulation</source>
            <year>1972</year>
            <month>Aug</month>
            <volume>46</volume>
            <issue>2</issue>
            <fpage>227</fpage>
            <page-range>227-39</page-range>
            <pub-id pub-id-type="pmid">5046018</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blanke</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Naoum</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dvir</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hahn</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Grayburn</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Moss</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Reisman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Piazza</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Leipsic</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Multimodality Imaging in the Context of Transcatheter Mitral Valve Replacement: Establishing Consensus Among Modalities and Disciplines.</article-title>
            <source>JACC Cardiovasc Imaging</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>8</volume>
            <issue>10</issue>
            <fpage>1191</fpage>
            <page-range>1191-1208</page-range>
            <pub-id pub-id-type="pmid">26481845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El Sabbagh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>YNV</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Mitral Valve Regurgitation in the Contemporary Era: Insights Into Diagnosis, Management, and Future Directions.</article-title>
            <source>JACC Cardiovasc Imaging</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>628</fpage>
            <page-range>628-643</page-range>
            <pub-id pub-id-type="pmid">29622181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dziadzko</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Clavel</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Dziadzko</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Medina-Inojosa</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Michelena</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Maalouf</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nkomo</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Thapa</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Enriquez-Sarano</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Outcome and undertreatment of mitral regurgitation: a community cohort study.</article-title>
            <source>Lancet</source>
            <year>2018</year>
            <month>Mar</month>
            <day>10</day>
            <volume>391</volume>
            <issue>10124</issue>
            <fpage>960</fpage>
            <page-range>960-969</page-range>
            <pub-id pub-id-type="pmid">29536860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Raney</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Echocardiography in mitral regurgitation with relevance to valve surgery.</article-title>
            <source>J Am Soc Echocardiogr</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>10</issue>
            <fpage>1086</fpage>
            <page-range>1086-91</page-range>
            <pub-id pub-id-type="pmid">21933744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shiota</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Role of echocardiography for catheter-based management of valvular heart disease.</article-title>
            <source>J Cardiol</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>69</volume>
            <issue>1</issue>
            <fpage>66</fpage>
            <page-range>66-73</page-range>
            <pub-id pub-id-type="pmid">27863908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asch</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Little</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Mackensen</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Grayburn</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Sorajja</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rinaldi</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Maisano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Incidence and standardised definitions of mitral valve leaflet adverse events after transcatheter mitral valve repair: the EXPAND study.</article-title>
            <source>EuroIntervention</source>
            <year>2021</year>
            <month>Dec</month>
            <day>03</day>
            <volume>17</volume>
            <issue>11</issue>
            <fpage>e932</fpage>
            <page-range>e932-e941</page-range>
            <pub-id pub-id-type="pmid">34031024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Avierinos</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Tribouilloy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Grigioni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Suri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Barbieri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Michelena</surname>
                <given-names>HI</given-names>
              </name>
              <name>
                <surname>Ionico</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rusinaru</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ansaldi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Habib</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Szymanski</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Giorgi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mahoney</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Enriquez-Sarano</surname>
                <given-names>M</given-names>
              </name>
              <collab>Mitral regurgitation International DAtabase (MIDA) Investigators</collab>
            </person-group>
            <article-title>Impact of ageing on presentation and outcome of mitral regurgitation due to flail leaflet: a multicentre international study.</article-title>
            <source>Eur Heart J</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>34</volume>
            <issue>33</issue>
            <fpage>2600</fpage>
            <page-range>2600-9</page-range>
            <pub-id pub-id-type="pmid">23853072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thaden</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Malouf</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Nkomo</surname>
                <given-names>VT</given-names>
              </name>
              <name>
                <surname>Pislaru</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Reeder</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Rihal</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Eleid</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Mitral Valve Anatomic Predictors of Hemodynamic Success With Transcatheter Mitral Valve Repair.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2018</year>
            <month>Jan</month>
            <day>13</day>
            <volume>7</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">29331957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Est&#x000e9;vez-Loureiro</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Franzen</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Winter</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sondergaard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jacobsen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Moat</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ihlemann</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ghione</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Duncan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Streit Rosenberg</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Barker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Di Mario</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Settergren</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Echocardiographic and clinical outcomes of central versus noncentral percutaneous edge-to-edge repair of degenerative mitral regurgitation.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2013</year>
            <month>Dec</month>
            <day>24</day>
            <volume>62</volume>
            <issue>25</issue>
            <fpage>2370</fpage>
            <page-range>2370-2377</page-range>
            <pub-id pub-id-type="pmid">24013059</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lapenna</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>De Bonis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sorrentino</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>La Canna</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Grimaldi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Torracca</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Maisano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Alfieri</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Commissural closure for the treatment of commissural mitral valve prolapse or flail.</article-title>
            <source>J Heart Valve Dis</source>
            <year>2008</year>
            <month>May</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>261</fpage>
            <page-range>261-6</page-range>
            <pub-id pub-id-type="pmid">18592922</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Katz</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Conrad Smith</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Crock</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Cavalcante</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Echocardiographic evaluation and guidance for MitraClip procedure.</article-title>
            <source>Cardiovasc Diagn Ther</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>7</volume>
            <issue>6</issue>
            <fpage>616</fpage>
            <page-range>616-632</page-range>
            <pub-id pub-id-type="pmid">29302467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Winkel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ong</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Brugger</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pilgrim</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Windecker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Praz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fam</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous Mitral Edge-to-Edge Repair: State of the Art and a Glimpse to the Future.</article-title>
            <source>Front Cardiovasc Med</source>
            <year>2019</year>
            <volume>6</volume>
            <fpage>122</fpage>
            <pub-id pub-id-type="pmid">31620446</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gertz</surname>
                <given-names>ZM</given-names>
              </name>
              <name>
                <surname>Herrmann</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Kar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kapadia</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Reed</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Puri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Krishnaswamy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gersh</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Weissman</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Asch</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Grayburn</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Kosmidou</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Redfors</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Lindenfeld</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Implications of Atrial Fibrillation on the Mechanisms of Mitral Regurgitation and Response to MitraClip in the COAPT Trial.</article-title>
            <source>Circ Cardiovasc Interv</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>e010300</fpage>
            <pub-id pub-id-type="pmid">33719505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abramowitz</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jilaihawi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chakravarty</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Makkar</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>Mitral Annulus Calcification.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2015</year>
            <month>Oct</month>
            <day>27</day>
            <volume>66</volume>
            <issue>17</issue>
            <fpage>1934</fpage>
            <page-range>1934-41</page-range>
            <pub-id pub-id-type="pmid">26493666</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fern&#x000e1;ndez-Peregrina</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pascual</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Freixa</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Tirado-Conte</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Est&#x000e9;vez-Loureiro</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Carrasco-Chinchilla</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Benito-Gonz&#x000e1;lez</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Asmarats</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sanch&#x000ed;s</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jim&#x000e9;nez-Quevedo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Avanzas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Caneiro-Queija</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Molina-Ramos</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez-V&#x000e1;zquez</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Flores-Umanzor</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sans-Rosell&#x000f3;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nombela-Franco</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Arzamendi</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Transcatheter edge-to-edge mitral valve repair in patients with mitral annulus calcification.</article-title>
            <source>EuroIntervention</source>
            <year>2022</year>
            <month>Mar</month>
            <day>18</day>
            <volume>17</volume>
            <issue>16</issue>
            <fpage>1300</fpage>
            <page-range>1300-1309</page-range>
            <pub-id pub-id-type="pmid">34483091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flint</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Raschpichler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rader</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Shmueli</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Asymptomatic Degenerative Mitral Regurgitation: A Review.</article-title>
            <source>JAMA Cardiol</source>
            <year>2020</year>
            <month>Mar</month>
            <day>01</day>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>346</fpage>
            <page-range>346-355</page-range>
            <pub-id pub-id-type="pmid">31995124</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flameng</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Herijgers</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bogaerts</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Recurrence of mitral valve regurgitation after mitral valve repair in degenerative valve disease.</article-title>
            <source>Circulation</source>
            <year>2003</year>
            <month>Apr</month>
            <day>01</day>
            <volume>107</volume>
            <issue>12</issue>
            <fpage>1609</fpage>
            <page-range>1609-13</page-range>
            <pub-id pub-id-type="pmid">12668494</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Joo</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Youn</surname>
                <given-names>YN</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Effect of Recurrent Mitral Regurgitation After Mitral Valve Repair in Patients With Degenerative Mitral Regurgitation.</article-title>
            <source>Circ J</source>
            <year>2017</year>
            <month>Dec</month>
            <day>25</day>
            <volume>82</volume>
            <issue>1</issue>
            <fpage>93</fpage>
            <page-range>93-101</page-range>
            <pub-id pub-id-type="pmid">28724839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehaffey</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Hawkins</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Schubert</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fonner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yarboro</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Quader</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Speir</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rich</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kron</surname>
                <given-names>IL</given-names>
              </name>
              <name>
                <surname>Ailawadi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Contemporary outcomes in reoperative mitral valve surgery.</article-title>
            <source>Heart</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>104</volume>
            <issue>8</issue>
            <fpage>652</fpage>
            <page-range>652-656</page-range>
            <pub-id pub-id-type="pmid">28982718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niikura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bae</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>G&#x000f6;ssl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jay</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sorajja</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Transcatheter therapy for residual mitral regurgitation after MitraClip therapy.</article-title>
            <source>EuroIntervention</source>
            <year>2019</year>
            <month>Aug</month>
            <day>09</day>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>e491</fpage>
            <page-range>e491-e499</page-range>
            <pub-id pub-id-type="pmid">31217145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Braun</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Frerker</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>K&#x000f6;rber</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Gaemperli</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Patzelt</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schaefer</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Hammerstingl</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Boekstegers</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ott</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ince</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Thiele</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hausleiter</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous Edge-to-Edge Repair of Recurrent Severe Mitral Regurgitation After Surgical Mitral Valve Repair.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2017</year>
            <month>Jul</month>
            <day>25</day>
            <volume>70</volume>
            <issue>4</issue>
            <fpage>504</fpage>
            <page-range>504-505</page-range>
            <pub-id pub-id-type="pmid">28728696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grasso</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ohno</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Attizzani</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Cannata</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Imm&#x000e8;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Barbanti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pistritto</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ministeri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Caggegi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chiarand&#x000e0;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dipasqua</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ronsivalle</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mangiafico</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Scandura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Capranzano</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Capodanno</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tamburino</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous mitral valve repair with the MitraClip system for severe mitral regurgitation in patients with surgical mitral valve repair failure.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2014</year>
            <month>Mar</month>
            <day>04</day>
            <volume>63</volume>
            <issue>8</issue>
            <fpage>836</fpage>
            <page-range>836-8</page-range>
            <pub-id pub-id-type="pmid">24161329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kanda</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Jay</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Farivar</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Sorajja</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Leaflet-to-Annuloplasty Ring Clipping for Severe Mitral Regurgitation.</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2016</year>
            <month>Apr</month>
            <day>11</day>
            <volume>9</volume>
            <issue>7</issue>
            <fpage>e63</fpage>
            <page-range>e63-4</page-range>
            <pub-id pub-id-type="pmid">26952908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>IY</given-names>
              </name>
              <name>
                <surname>Barajas</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Hahn</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>The MitraClip Procedure-A Comprehensive Review for the Cardiac Anesthesiologist.</article-title>
            <source>J Cardiothorac Vasc Anesth</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>2746</fpage>
            <page-range>2746-2759</page-range>
            <pub-id pub-id-type="pmid">30268642</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hahn</surname>
                <given-names>RT</given-names>
              </name>
            </person-group>
            <article-title>Transcathether Valve Replacement and Valve Repair: Review of Procedures and Intraprocedural Echocardiographic Imaging.</article-title>
            <source>Circ Res</source>
            <year>2016</year>
            <month>Jul</month>
            <day>08</day>
            <volume>119</volume>
            <issue>2</issue>
            <fpage>341</fpage>
            <page-range>341-56</page-range>
            <pub-id pub-id-type="pmid">27390336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hahn</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Current Indications for Transcatheter Edge-to-Edge Repair in a Patient With Primary Mitral Regurgitation.</article-title>
            <source>Circulation</source>
            <year>2022</year>
            <month>Oct</month>
            <day>25</day>
            <volume>146</volume>
            <issue>17</issue>
            <fpage>1263</fpage>
            <page-range>1263-1265</page-range>
            <pub-id pub-id-type="pmid">36279415</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chikwe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Milojevic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wijeysundera</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Biondi-Zoccai</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Flather</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gaudino</surname>
                <given-names>MFL</given-names>
              </name>
              <name>
                <surname>Fremes</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Tam</surname>
                <given-names>DY</given-names>
              </name>
            </person-group>
            <article-title>ESC/EACTS vs. ACC/AHA guidelines for the management of severe aortic stenosis.</article-title>
            <source>Eur Heart J</source>
            <year>2023</year>
            <month>Mar</month>
            <day>07</day>
            <volume>44</volume>
            <issue>10</issue>
            <fpage>796</fpage>
            <page-range>796-812</page-range>
            <pub-id pub-id-type="pmid">36632841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Russell</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Costello</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>McLellan</surname>
                <given-names>AJA</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Reid</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Maguire</surname>
                <given-names>GP</given-names>
              </name>
            </person-group>
            <article-title>Medical Management of Rheumatic Heart Disease: A Systematic Review of the Evidence.</article-title>
            <source>Cardiol Rev</source>
            <year>2018</year>
            <season>Jul/Aug</season>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>187</fpage>
            <page-range>187-195</page-range>
            <pub-id pub-id-type="pmid">29608495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Praet</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Stamm</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>S&#x000fc;ndermann</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Unbehaun</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Montagner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nazari Shafti</surname>
                <given-names>TZ</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Falk</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kempfert</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Minimally Invasive Surgical Mitral Valve Repair: State of the Art Review.</article-title>
            <source>Interv Cardiol</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>14</fpage>
            <page-range>14-19</page-range>
            <pub-id pub-id-type="pmid">29593831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taramasso</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gaemperli</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Maisano</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Treatment of degenerative mitral regurgitation in elderly patients.</article-title>
            <source>Nat Rev Cardiol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>177</fpage>
            <page-range>177-83</page-range>
            <pub-id pub-id-type="pmid">25533801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asch</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Grayburn</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Kar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Zaroff</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Mishell</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Whisenant</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Lindenfeld</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Weissman</surname>
                <given-names>NJ</given-names>
              </name>
              <collab>COAPT Investigators</collab>
            </person-group>
            <article-title>Echocardiographic Outcomes After Transcatheter Leaflet Approximation in&#x000a0;Patients With Secondary Mitral&#x000a0;Regurgitation: The COAPT Trial.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2019</year>
            <month>Dec</month>
            <day>17</day>
            <volume>74</volume>
            <issue>24</issue>
            <fpage>2969</fpage>
            <page-range>2969-2979</page-range>
            <pub-id pub-id-type="pmid">31574303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishimura</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Vahanian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Eleid</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Mitral valve disease--current management and future challenges.</article-title>
            <source>Lancet</source>
            <year>2016</year>
            <month>Mar</month>
            <day>26</day>
            <volume>387</volume>
            <issue>10025</issue>
            <fpage>1324</fpage>
            <page-range>1324-34</page-range>
            <pub-id pub-id-type="pmid">27025438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chakravarty</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Makar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Oakley</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Stegic</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Skaf</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Makkar</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>Transcatheter Edge-to-Edge Mitral Valve Repair With the MitraClip G4 System.</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2020</year>
            <month>Oct</month>
            <day>26</day>
            <volume>13</volume>
            <issue>20</issue>
            <fpage>2402</fpage>
            <page-range>2402-2414</page-range>
            <pub-id pub-id-type="pmid">33011141</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Praz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Braun</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Unterhuber</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spirito</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Orban</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brugger</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Brinkmann</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Spring</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Moschovitis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nabauer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blazek</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pilgrim</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Thiele</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lurz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hausleiter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Windecker</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Edge-to-Edge Mitral Valve Repair With Extended Clip Arms: Early Experience From a Multicenter Observational Study.</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2019</year>
            <month>Jul</month>
            <day>22</day>
            <volume>12</volume>
            <issue>14</issue>
            <fpage>1356</fpage>
            <page-range>1356-1365</page-range>
            <pub-id pub-id-type="pmid">31129091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Praz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Spargias</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chrissoheris</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>B&#x000fc;llesfeld</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nickenig</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Deuschl</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schueler</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fam</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Moss</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Makar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boone</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moschovitis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sch&#x000e4;fer</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Windecker</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study.</article-title>
            <source>Lancet</source>
            <year>2017</year>
            <month>Aug</month>
            <day>19</day>
            <volume>390</volume>
            <issue>10096</issue>
            <fpage>773</fpage>
            <page-range>773-780</page-range>
            <pub-id pub-id-type="pmid">28831993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hausleiter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stocker</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Adamo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Karam</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Swaans</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Praz</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Mitral valve transcatheter edge-to-edge repair.</article-title>
            <source>EuroIntervention</source>
            <year>2023</year>
            <month>Jan</month>
            <day>23</day>
            <volume>18</volume>
            <issue>12</issue>
            <fpage>957</fpage>
            <page-range>957-976</page-range>
            <pub-id pub-id-type="pmid">36688459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Abdullah</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Aspelund</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Barnhart</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Calkins</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Cowles</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Downard</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Goldin</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>St Peter</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Arca</surname>
                <given-names>MJ</given-names>
              </name>
              <collab>2011 American Pediatric Surgical Association Outcomes and Clinical Trials Committee</collab>
            </person-group>
            <article-title>Strategies for the prevention of central venous catheter infections: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review.</article-title>
            <source>J Pediatr Surg</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>46</volume>
            <issue>10</issue>
            <fpage>2000</fpage>
            <page-range>2000-11</page-range>
            <pub-id pub-id-type="pmid">22008341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kassar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Praz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hunziker</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pilgrim</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Windecker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Seiler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brugger</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Anatomical and Technical Predictors of Three-Dimensional Mitral Valve Area Reduction After Transcatheter Edge-To-Edge Repair.</article-title>
            <source>J Am Soc Echocardiogr</source>
            <year>2022</year>
            <month>Jan</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>96</fpage>
            <page-range>96-104</page-range>
            <pub-id pub-id-type="pmid">34506920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Multi-MitraClip therapy for severe degenerative mitral regurgitation: "anchor" technique for extremely flail segments.</article-title>
            <source>Catheter Cardiovasc Interv</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>86</volume>
            <issue>2</issue>
            <fpage>339</fpage>
            <page-range>339-46</page-range>
            <pub-id pub-id-type="pmid">25559345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oguz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Padang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rashedi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Pislaru</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Nkomo</surname>
                <given-names>VT</given-names>
              </name>
              <name>
                <surname>Mankad</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Malouf</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Guerrero</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Reeder</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Eleid</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Rihal</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Thaden</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Risk for Increased Mean Diastolic Gradient after Transcatheter Edge-to-Edge Mitral Valve Repair: A Quantitative Three-Dimensional Transesophageal Echocardiographic Analysis.</article-title>
            <source>J Am Soc Echocardiogr</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>34</volume>
            <issue>6</issue>
            <fpage>595</fpage>
            <page-range>595-603.e2</page-range>
            <pub-id pub-id-type="pmid">33524491</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naqvi</surname>
                <given-names>TZ</given-names>
              </name>
            </person-group>
            <article-title>Echocardiography in percutaneous valve therapy.</article-title>
            <source>JACC Cardiovasc Imaging</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>2</volume>
            <issue>10</issue>
            <fpage>1226</fpage>
            <page-range>1226-37</page-range>
            <pub-id pub-id-type="pmid">19833314</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hahn</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Saric</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Faletra</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gillam</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Horton</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Khalique</surname>
                <given-names>OK</given-names>
              </name>
              <name>
                <surname>Little</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Mackensen</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Quader</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Safi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Scalia</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Recommended Standards for the Performance of Transesophageal Echocardiographic Screening for Structural Heart Intervention: From the American Society of Echocardiography.</article-title>
            <source>J Am Soc Echocardiogr</source>
            <year>2022</year>
            <month>Jan</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-76</page-range>
            <pub-id pub-id-type="pmid">34280494</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lancellotti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tribouilloy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hagendorff</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Popescu</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Edvardsen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pierard</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Badano</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zamorano</surname>
                <given-names>JL</given-names>
              </name>
              <collab>Scientific Document Committee of the European Association of Cardiovascular Imaging</collab>
            </person-group>
            <article-title>Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging.</article-title>
            <source>Eur Heart J Cardiovasc Imaging</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>14</volume>
            <issue>7</issue>
            <fpage>611</fpage>
            <page-range>611-44</page-range>
            <pub-id pub-id-type="pmid">23733442</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alkhouli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rihal</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Transseptal Techniques for Emerging&#x000a0;Structural Heart Interventions.</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2016</year>
            <month>Dec</month>
            <day>26</day>
            <volume>9</volume>
            <issue>24</issue>
            <fpage>2465</fpage>
            <page-range>2465-2480</page-range>
            <pub-id pub-id-type="pmid">28007198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sherif</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Paranskaya</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yuecel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kische</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thiele</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>D'Ancona</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Neuhausen-Abramkina</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ortak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ince</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>&#x000d6;ner</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>MitraClip step by step; how to simplify the procedure.</article-title>
            <source>Neth Heart J</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>125</fpage>
            <page-range>125-130</page-range>
            <pub-id pub-id-type="pmid">27933588</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Swaans</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Van den Branden</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Van der Heyden</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Post</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Rensing</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Eefting</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Plokker</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Jaarsma</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Three-dimensional transoesophageal echocardiography in a patient undergoing percutaneous mitral valve repair using the edge-to-edge clip technique.</article-title>
            <source>Eur J Echocardiogr</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>8</issue>
            <fpage>982</fpage>
            <page-range>982-3</page-range>
            <pub-id pub-id-type="pmid">19654135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maslow</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mahmood</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Poppas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Three-dimensional echocardiographic assessment of the repaired mitral valve.</article-title>
            <source>J Cardiothorac Vasc Anesth</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-17</page-range>
            <pub-id pub-id-type="pmid">24075641</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saitoh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Izumo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Furugen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Miyata-Fukuoka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gurudevan</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Tolstrup</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Kar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shiota</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Echocardiographic evaluation of iatrogenic atrial septal defect after catheter-based mitral valve clip insertion.</article-title>
            <source>Am J Cardiol</source>
            <year>2012</year>
            <month>Jun</month>
            <day>15</day>
            <volume>109</volume>
            <issue>12</issue>
            <fpage>1787</fpage>
            <page-range>1787-91</page-range>
            <pub-id pub-id-type="pmid">22475361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Writing Committee Members</collab>
              <name>
                <surname>Otto</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Bonow</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Carabello</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Erwin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Gentile</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jneid</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Krieger</surname>
                <given-names>EV</given-names>
              </name>
              <name>
                <surname>Mack</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Rigolin</surname>
                <given-names>VH</given-names>
              </name>
              <name>
                <surname>Sundt</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Toly</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2021</year>
            <month>Feb</month>
            <day>02</day>
            <volume>77</volume>
            <issue>4</issue>
            <fpage>450</fpage>
            <page-range>450-500</page-range>
            <pub-id pub-id-type="pmid">33342587</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nickenig</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Estevez-Loureiro</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Franzen</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Tamburino</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vanderheyden</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>L&#x000fc;scher</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Moat</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dall'Ara</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Winter</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Corti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Grasso</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Snow</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Jeger</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Blankenberg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Settergren</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tiroch</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Balzer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Petronio</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>B&#x000fc;ttner</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Ettori</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sievert</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fiorino</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Claeys</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ussia</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Baumgartner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Scandura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Alamgir</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Keshavarzi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maisano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ebelt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Aruta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lubos</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Plicht</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Schueler</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pighi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Di Mario</surname>
                <given-names>C</given-names>
              </name>
              <collab>Transcatheter Valve Treatment Sentinel Registry Investigators of the EURObservational Research Programme of the European Society of Cardiology</collab>
            </person-group>
            <article-title>Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2014</year>
            <month>Sep</month>
            <day>02</day>
            <volume>64</volume>
            <issue>9</issue>
            <fpage>875</fpage>
            <page-range>875-84</page-range>
            <pub-id pub-id-type="pmid">25169171</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schnitzler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hell</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Geyer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kreidel</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>M&#x000fc;nzel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>von Bardeleben</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Complications Following MitraClip Implantation.</article-title>
            <source>Curr Cardiol Rep</source>
            <year>2021</year>
            <month>Aug</month>
            <day>13</day>
            <volume>23</volume>
            <issue>9</issue>
            <fpage>131</fpage>
            <pub-id pub-id-type="pmid">34387748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sticchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bartkowiak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brugger</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Windecker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Praz</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Retrograde Retrieval of a Novel Large Mitral Clip After Embolization Into the Left Ventricle.</article-title>
            <source>JACC Case Rep</source>
            <year>2021</year>
            <month>Oct</month>
            <day>20</day>
            <volume>3</volume>
            <issue>14</issue>
            <fpage>1561</fpage>
            <page-range>1561-1568</page-range>
            <pub-id pub-id-type="pmid">34729501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hamm</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Barth</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Diegeler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kerber</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Stroke and thrombus formation appending to the MitraClip: what is the appropriate anticoagulation regimen?</article-title>
            <source>J Heart Valve Dis</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>713</fpage>
            <page-range>713-5</page-range>
            <pub-id pub-id-type="pmid">24383386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakajima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>First experience of the usage of a GORE CARDIOFORM Septal Occluder device for treatment of a significant residual commissural mitral regurgitation jet following a MitraClip procedure.</article-title>
            <source>Catheter Cardiovasc Interv</source>
            <year>2018</year>
            <month>Sep</month>
            <day>01</day>
            <volume>92</volume>
            <issue>3</issue>
            <fpage>607</fpage>
            <page-range>607-610</page-range>
            <pub-id pub-id-type="pmid">29219253</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mangieri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Melillo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Montalto</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Denti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Praz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sala</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Winkel</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Taramasso</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tagliari</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Fam</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Rubbio</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>De Marco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bedogni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Toggweiler</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schofer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brinkmann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sievert</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Van Mieghem</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Ooms</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Paradis</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Rod&#x000e9;s-Cabau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brochet</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Himbert</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Perl</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kornowski</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ielasi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Regazzoli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Baldetti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Masiero</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tarantini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Latib</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Laricchia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gattas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tchetch&#x000e8;</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dumonteil</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Francesco</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Agricola</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Montorfano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lurz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Crimi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Maisano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Management and Outcome of Failed&#x000a0;Percutaneous Edge-to-Edge Mitral&#x000a0;Valve&#x000a0;Plasty: Insight From an International Registry.</article-title>
            <source>JACC Cardiovasc Interv</source>
            <year>2022</year>
            <month>Feb</month>
            <day>28</day>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>411</fpage>
            <page-range>411-422</page-range>
            <pub-id pub-id-type="pmid">35210047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alessandrini</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dreher</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Harr</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wohlmuth</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Meincke</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hakmi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ubben</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kuck</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Willems</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schmoeckel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Geidel</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical impact of intervention strategies after failed transcatheter mitral valve repair.</article-title>
            <source>EuroIntervention</source>
            <year>2021</year>
            <month>Apr</month>
            <day>20</day>
            <volume>16</volume>
            <issue>17</issue>
            <fpage>1447</fpage>
            <page-range>1447-1454</page-range>
            <pub-id pub-id-type="pmid">33074154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-179.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lavall</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Reil</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Segura Schmitz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mehrer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schirmer</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>B&#x000f6;hm</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Laufs</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Early Hemodynamic Improvement after Percutaneous Mitral Valve Repair Evaluated by Noninvasive Pressure-Volume Analysis.</article-title>
            <source>J Am Soc Echocardiogr</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>29</volume>
            <issue>9</issue>
            <fpage>888</fpage>
            <page-range>888-98</page-range>
            <pub-id pub-id-type="pmid">27372560</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
